Robert Post - Publications

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 

128/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bennett F, Hodgetts S, Close A, Frye M, Grunze H, Keck P, Kupka R, McElroy S, Nolen W, Post R, Schärer L, Suppes T, Sharma AN. Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network. International Journal of Bipolar Disorders. 7: 28. PMID 31840207 DOI: 10.1186/S40345-019-0169-5  0.324
2017 Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, McGorry PD, Fernandes BS, Yatham LN, Dodd S. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 236-244. PMID 28941093 DOI: 10.1002/Wps.20441  0.314
2015 Xing G, Weiss S, Post R. Low Frequency Stimulation (Quenching) Affects Amygdala Kindling-Induced Gene Expression in Rat Brain Brain Stimulation. 8: 414-415. DOI: 10.1016/j.brs.2015.01.322  0.344
2014 Benson BE, Willis MW, Ketter TA, Speer A, Kimbrell TA, Herscovitch P, George MS, Post RM. Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders. Journal of Affective Disorders. 168: 243-53. PMID 25069080 DOI: 10.1016/J.Jad.2014.05.045  0.572
2012 Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. The Journal of Clinical Psychiatry. 73: 924-30. PMID 22480597 DOI: 10.4088/Jcp.11M07396  0.486
2011 George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. The American Journal of Psychiatry. 168: 356-64. PMID 21474597 DOI: 10.1176/Appi.Ajp.2010.10060864  0.573
2011 Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R. Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research. 45: 156-61. PMID 20541770 DOI: 10.1016/J.Jpsychires.2010.05.015  0.371
2010 Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. The American Journal of Psychiatry. 167: 708-15. PMID 20231325 DOI: 10.1176/Appi.Ajp.2009.09010105  0.306
2009 Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. The Journal of Clinical Psychiatry. 70: 1273-80. PMID 19689918 DOI: 10.4088/Jcp.08M04381  0.471
2009 Speer AM, Benson BE, Kimbrell TK, Wassermann EM, Willis MW, Herscovitch P, Post RM. Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. Journal of Affective Disorders. 115: 386-94. PMID 19027962 DOI: 10.1016/J.Jad.2008.10.006  0.301
2008 Benson BE, Willis MW, Ketter TA, Speer A, Kimbrell TA, George MS, Herscovitch P, Post RM. Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders. Psychiatry Research. 164: 30-47. PMID 18801648 DOI: 10.1016/J.Pscychresns.2007.12.016  0.596
2008 Willis MW, Benson BE, Ketter TA, Kimbrell TA, George MS, Speer AM, Herscovitch P, Post RM. Interregional cerebral metabolic associativity during a continuous performance task (Part I): healthy adults. Psychiatry Research. 164: 16-29. PMID 18799294 DOI: 10.1016/J.Pscychresns.2007.12.015  0.566
2006 Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. The British Journal of Psychiatry : the Journal of Mental Science. 189: 124-31. PMID 16880481 DOI: 10.1192/bjp.bp.105.013045  0.301
2006 Xing G, Zhang L, Russell S, Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophrenia Research. 84: 36-56. PMID 16631355 DOI: 10.1016/j.schres.2005.11.006  0.341
2006 Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. The American Journal of Psychiatry. 163: 313-5. PMID 16449487 DOI: 10.1176/Appi.Ajp.163.2.313  0.405
2005 Post RM. The impact of bipolar depression. The Journal of Clinical Psychiatry. 66: 5-10. PMID 16038596  0.308
2005 Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich G, Grunze H, ... ... Post R, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disorders. 7: 246-59. PMID 15898962 DOI: 10.1111/J.1399-5618.2005.00201.X  0.339
2005 Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. The Journal of Clinical Psychiatry. 66: 370-4. PMID 15766304 DOI: 10.4088/Jcp.V66N0314  0.303
2003 Altshuler L, Suppes T, Black D, Nolen WA, Keck PE, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. The American Journal of Psychiatry. 160: 1252-62. PMID 12832239 DOI: 10.1176/Appi.Ajp.160.7.1252  0.391
2003 Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry. 53: 906-13. PMID 12742678 DOI: 10.1016/S0006-3223(02)01911-X  0.374
2003 Frye MA, Pazzaglia PJ, George MS, Luckenbaugh DA, Vanderham E, Davis CL, Rubinow DR, Post RM. Low CSF somatostatin associated with response to nimodipine in patents with affective illness. Biological Psychiatry. 53: 180-3. PMID 12547475 DOI: 10.1016/S0006-3223(02)01343-4  0.587
2003 Post RM. Prevalence of Bipolar Depression Cns Spectrums. 8: 2-3. DOI: 10.1017/S1092852900028765  0.306
2002 Kimbrell TA, Dunn RT, George MS, Danielson AL, Willis MW, Repella JD, Benson BE, Herscovitch P, Post RM, Wassermann EM. Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Research. 115: 101-13. PMID 12208488 DOI: 10.1016/S0925-4927(02)00041-0  0.553
2002 Xing G, Russell S, Hough C, O'Grady J, Zhang L, Yang S, Zhang LX, Post R. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport. 13: 501-5. PMID 11930170 DOI: 10.1097/00001756-200203250-00029  0.302
2002 Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, ... ... Post R, et al. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Archives of General Psychiatry. 59: 262-70. PMID 11879164 DOI: 10.1001/Archpsyc.59.3.262  0.407
2002 Willis MW, Ketter TA, Kimbrell TA, George MS, Herscovitch P, Danielson AL, Benson BE, Post RM. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Research. 114: 23-37. PMID 11864807 DOI: 10.1016/S0925-4927(01)00126-3  0.512
2002 Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry. 51: 237-52. PMID 11839367 DOI: 10.1016/S0006-3223(01)01216-1  0.592
2001 Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, Willis MW, Danielson A, Frye MA, Herscovitch P, Post RM. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry. 49: 97-109. PMID 11164756 DOI: 10.1016/S0006-3223(00)00975-6  0.625
2000 Akiskal HS, Bourgeois ML, Angst J, Post R, Möller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. Journal of Affective Disorders. 59: S5-S30. PMID 11121824 DOI: 10.1016/S0165-0327(00)00203-2  0.418
2000 Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW, Herscovitch P, Post RM. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biological Psychiatry. 48: 1020-3. PMID 11082477 DOI: 10.1016/S0006-3223(00)00920-3  0.592
1999 Altshuler LL, Keck PE, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disorders. 1: 61-5. PMID 11256659 DOI: 10.1034/J.1399-5618.1999.10113.X  0.387
1999 Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, Repella JD, Danielson AL, Willis MW, Benson BE, Speer AM, Osuch E, George MS, Post RM. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry. 46: 1603-13. PMID 10624541 DOI: 10.1016/S0006-3223(99)00195-X  0.404
1999 Ketter TA, Kimbrell TA, George MS, Willis MW, Benson BE, Danielson A, Frye MA, Herscovitch P, Post RM. Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. Biological Psychiatry. 46: 1364-74. PMID 10578451 DOI: 10.1016/S0006-3223(99)00210-3  0.57
1999 Kimbrell TA, George MS, Parekh PI, Ketter TA, Podell DM, Danielson AL, Repella JD, Benson BE, Willis MW, Herscovitch P, Post RM. Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biological Psychiatry. 46: 454-65. PMID 10459394 DOI: 10.1016/S0006-3223(99)00103-1  0.556
1999 Frye MA, Gary KA, Marangell LB, George MS, Callahan AM, Little JT, Huggins T, Corá-Locatelli G, Osuch EA, Winokur A, Post RM. CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 349-53. PMID 10440011 DOI: 10.1176/Jnp.11.3.349  0.566
1999 Hough C, Lu SJ, Davis CL, Chuang DM, Post RM. Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay. Biological Psychiatry. 46: 247-55. PMID 10418700 DOI: 10.1016/S0006-3223(98)00308-4  0.472
1998 Pazzaglia PJ, Post RM, Ketter TA, Callahan AM, Marangell LB, Frye MA, George MS, Kimbrell TA, Leverich GS, Cora-Locatelli G, Luckenbaugh D. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. Journal of Clinical Psychopharmacology. 18: 404-13. PMID 9790159 DOI: 10.1097/00004714-199810000-00009  0.562
1998 Weiss SRB, Post RM. Kindling: Separate vs. shared mechanisms in affective disorders and epilepsy Neuropsychobiology. 38: 167-180. PMID 9778605 DOI: 10.1159/000026533  0.309
1998 George MS, Huggins T, McDermut W, Parekh PI, Rubinow D, Post RM. Abnormal facial emotion recognition in depression: serial testing in an ultra-rapid-cycling patient. Behavior Modification. 22: 192-204. PMID 9563292 DOI: 10.1177/01454455980222007  0.554
1998 Li H, Weiss SR, Chuang DM, Post RM, Rogawski MA. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-alpha-ethylglutamic acid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1662-70. PMID 9464991 DOI: 10.1523/Jneurosci.18-05-01662.1998  0.43
1998 George M, Nahas Z, Speer A, Avery D, Molloy M, Risch S, Lorberbaum J, Bohning D, Post R. 253. How does TMS improve depression?: Current hints about the role of intensity, frequency, location and dose Biological Psychiatry. 43: S76. DOI: 10.1016/S0006-3223(98)90701-6  0.649
1998 George MS, Speer AM, Molloy M, Nahas Z, Teneback CC, Risch SC, Arana GW, Ballenger JC, Post RM. Low frequency daily left prefrontal rTMS improves mood in bipolar depression: A placebo-controlled case report Human Psychopharmacology. 13: 271-275. DOI: 10.1002/(Sici)1099-1077(199806)13:4<271::Aid-Hup995>3.0.Co;2-G  0.706
1997 George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, Greenberg BD, Hallett M, Post RM. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. The American Journal of Psychiatry. 154: 1752-6. PMID 9396958 DOI: 10.1176/Ajp.154.12.1752  0.568
1997 Xing G, Zhang L, Zhang L, Heynen T, Li XL, Smith MA, Weiss SR, Feldman AN, Detera-Wadleigh S, Chuang DM, Post RM. Rat nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. Brain Research. Molecular Brain Research. 47: 251-61. PMID 9221923 DOI: 10.1016/S0169-328X(97)00056-9  0.414
1997 Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M, Wassermann EM, Post RM, Murphy DL. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. The American Journal of Psychiatry. 154: 867-9. PMID 9167520 DOI: 10.1176/Ajp.154.6.867  0.552
1997 Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L'Herrou TA, Leverich GS, Post RM. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Archives of General Psychiatry. 54: 214-22. PMID 9075462 DOI: 10.1001/Archpsyc.1997.01830150034007  0.59
1997 Callahan AM, Frye MA, Marangell LB, George MS, Ketter TA, L'Herrou T, Post RM. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biological Psychiatry. 41: 264-72. PMID 9024949 DOI: 10.1016/S0006-3223(97)00372-7  0.571
1997 George MS, Ketter TA, Parekh PI, Rosinsky N, Ring HA, Pazzaglia PJ, Marangell LB, Callahan AM, Post RM. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 55-63. PMID 9017529 DOI: 10.1176/JNP.9.1.55  0.58
1997 Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P, Andreason PJ, Horwitz B, Herscovitch P, Post RM. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. The American Journal of Psychiatry. 154: 224-30. PMID 9016272 DOI: 10.1176/Ajp.154.2.224  0.534
1997 George MS, Ketter TA, Parekh PI, Gill DS, Marangell L, Pazzaglia PJ, Herscovitch P, Post RM. Depressed Subjects Have Decreased rCBF Activation During Facial Emotion Recognition Cns Spectrums. 2: 45-55. DOI: 10.1017/S1092852900011081  0.577
1997 Post RM, Kimbrell T, Frye M, George M, McCann U, Little J, Dunn R, Li H, Weiss S. Implications of Kindling And Quenching For the Possible Frequency Dependence Of rTMS Cns Spectrums. 2: 54-60. DOI: 10.1017/S1092852900004508  0.509
1997 George MS, Speer AM, Wassermann EM, Kimbrell TA, William WA, Kellner CH, Risch SC, Stallings L, Post RM. Repetitive TMS as a Probe of Mood In Health and Disease Cns Spectrums. 2: 39-44. DOI: 10.1017/S1092852900004478  0.517
1997 Martin JD, George MS, Greenberg BD, Wassermann EM, Schlaepfer TE, Murphy DL, Hallett M, Post RM. Mood effects of prefrontal repetitive high-frequency TMS in healthy volunteers Cns Spectrums. 2: 53-60.  0.519
1996 George MS, Wassermann EM, Post RM. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 373-82. PMID 9116472 DOI: 10.1176/Jnp.8.4.373  0.519
1996 George MS, Wassermann EM, Williams WA, Steppel J, Pascual-Leone A, Basser P, Hallett M, Post RM. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 172-80. PMID 9081553 DOI: 10.1176/JNP.8.2.172  0.534
1996 Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology. 128: 115-29. PMID 8956373 DOI: 10.1007/S002130050117  0.468
1996 George MS, Parekh PI, Rosinsky N, Ketter TA, Kimbrell TA, Heilman KM, Herscovitch P, Post RM. Understanding emotional prosody activates right hemisphere regions. Archives of Neurology. 53: 665-70. PMID 8929174 DOI: 10.1001/Archneur.1996.00550070103017  0.515
1996 George MS, Ketter TA, Parekh PI, Herscovitch P, Post RM. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biological Psychiatry. 40: 859-71. PMID 8896772 DOI: 10.1016/0006-3223(95)00572-2  0.531
1996 Ketter TA, Flockhart DA, Post RM, Denicoff K, Pazzaglia PJ, Marangell LB, George MS, Callahan AM. The emerging role of cytochrome P450 3A in psychopharmacology. Journal of Clinical Psychopharmacology. 15: 387-98. PMID 8748427 DOI: 10.1097/00004714-199512000-00002  0.49
1996 Poltorak M, Frye MA, Wright R, Hemperly JJ, George MS, Pazzaglia PJ, Jerrels SA, Post RM, Freed WJ. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. Journal of Neurochemistry. 66: 1532-8. PMID 8627309 DOI: 10.1046/J.1471-4159.1996.66041532.X  0.453
1996 Ketter TA, Andreason PJ, George MS, Lee C, Gill DS, Parekh PI, Willis MW, Herscovitch P, Post RM. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Archives of General Psychiatry. 53: 59-69. PMID 8540778 DOI: 10.1001/Archpsyc.1996.01830010061009  0.374
1996 Ketter TA, George MS, Kimbrell TA, Benson BE, Post RM. Functional Brain Imaging, Limbic Function, and Affective Disorders The Neuroscientist. 2: 55-65. DOI: 10.1177/107385849600200113  0.571
1996 Post RM, Weiss SRB, Leverich GS, George MS, Frye M, Ketter TA. Developmental psychobiology of cyclic affective illness: Implications for early therapeutic intervention Development and Psychopathology. 8: 273-305. DOI: 10.1017/S0954579400007082  0.547
1996 Ketter T, Kimbrell T, George M, Stein R, Willis M, Benson B, Frye M, Corá-Locatelli G, Post R. Baseline hypermetabolism may predict carbamazepine response, and hypometabolism nimodipine response in mood disorders European Neuropsychopharmacology. 6: 10. DOI: 10.1016/0924-977X(96)87339-1  0.531
1996 Frye M, Mathe A, Gary K, George M, Corà-Locatelli G, Huggins T, Pazzaglia P, Callahan A, Davis C, Marangell L, Rubinow D, Winokur A, Post R. CSF neuropeptide dysregulation in patients with affective disorder Biological Psychiatry. 39: 596. DOI: 10.1016/0006-3223(96)84272-7  0.569
1995 Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS, Callahan AM, Hinton ML, Chao J, Post RM. Carbamazepine but not valproate induces bupropion metabolism. Journal of Clinical Psychopharmacology. 15: 327-33. PMID 8830063 DOI: 10.1097/00004714-199510000-00004  0.515
1995 Gao XM, Margolis RL, Leeds P, Hough C, Post RM, Chuang DM. Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-D-aspartate, aurintricarboxylic acid and cycloheximide. Brain Research. 703: 63-71. PMID 8719616 DOI: 10.1016/0006-8993(95)01066-1  0.542
1995 George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 6: 1853-6. PMID 8547583 DOI: 10.1097/00001756-199510020-00008  0.585
1995 Pazzaglia PJ, George MS, Post RM, Rubinow DR, Davis CL. Nimodipine increases CSF somatostatin in affectively Ill patients Neuropsychopharmacology. 13: 75-83. PMID 8526973 DOI: 10.1016/0893-133X(95)00024-8  0.577
1995 George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM. Brain activity during transient sadness and happiness in healthy women. The American Journal of Psychiatry. 152: 341-51. PMID 7864258 DOI: 10.1176/Ajp.152.3.341  0.516
1995 Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. The American Journal of Psychiatry. 152: 1139-44. PMID 7625460 DOI: 10.1176/Ajp.152.8.1139  0.369
1995 Parekh PI, Spencer JW, George MS, Gill DS, Ketter TA, Andreason P, Herscovitch P, Post RM. Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity. Brain Topography. 7: 209-16. PMID 7599020 DOI: 10.1007/Bf01202380  0.53
1995 Mathé A, George M, Frye M, Post R. Elevated concentrations of CSF CGRP might be a trait marker for affective illness Biological Psychiatry. 37: 654. DOI: 10.1016/0006-3223(95)94631-6  0.498
1995 Kimbrell T, George M, Parekh P, Ketter T, Herscovitch P, Post R. Regional brain activity during self-induced anger and anxiety Biological Psychiatry. 37: 617-618. DOI: 10.1016/0006-3223(95)94504-P  0.514
1995 George M, Mathé A, Frye M, Davis C, Pazzaglia P, Rubinow D, Jerrels S, Post R. CSF CGRP correlates with neuropeptides in controls but not affective illness Biological Psychiatry. 37: 610. DOI: 10.1016/0006-3223(95)94476-D  0.595
1995 Frye M, Mathé A, George M, Pazzaglia P, Jerrels S, Post R. CSF neuropeptide Y in mood disorders and treatment with carbamazepine Biological Psychiatry. 37: 609-610. DOI: 10.1016/0006-3223(95)94475-C  0.558
1995 Callahan A, Frye M, Marangell L, George M, Ketter T, Kimbrell T, L'Herrou T, Pazzaglia P, Post R. Differential mood and endocrine effects of intravenous vs. intrathecal TRH Biological Psychiatry. 37: 609. DOI: 10.1016/0006-3223(95)94474-B  0.371
1994 George MS, Ketter TA, Parekh PI, Rosinsky N, Ring H, Casey BJ, Trimble MR, Horwitz B, Herscovitch P, Post RM. Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Human Brain Mapping. 1: 194-209. PMID 24578040 DOI: 10.1002/Hbm.460010305  0.528
1994 Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Research. 49: 257-72. PMID 8177920 DOI: 10.1016/0165-1781(93)90066-P  0.553
1994 Margolis RL, Chuang DM, Post RM. Programmed cell death: implications for neuropsychiatric disorders. Biological Psychiatry. 35: 946-56. PMID 8080894 DOI: 10.1016/0006-3223(94)91241-6  0.573
1994 George MS, Guidotti A, Rubinow D, Pan B, Mikalauskas K, Post RM. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biological Psychiatry. 35: 775-80. PMID 8043707 DOI: 10.1016/0006-3223(94)91139-8  0.581
1994 Marangell LB, George MS, Bissette G, Pazzaglia P, Huggins T, Post RM. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients. Archives of General Psychiatry. 51: 625-8. PMID 8042911 DOI: 10.1001/Archpsyc.1994.03950080037005  0.54
1994 George MS, Rosenstein D, Rubinow DR, Kling MA, Post RM. CSF magnesium in affective disorder: Lack of correlation with clinical course of treatment Psychiatry Research. 51: 139-146. PMID 8022948 DOI: 10.1016/0165-1781(94)90033-7  0.585
1994 George MS, Ketter TA, Post RM. Activation Studies in Mood Disorders Psychiatric Annals. 24: 648-652. DOI: 10.3928/0048-5713-19941201-09  0.555
1994 Ketter TA, George MS, Ring HA, Pazzaglia P, Marangell L, Kimbrell TA, Post RM. Primary Mood Disorders: Structural and Resting Functional Studies Psychiatric Annals. 24: 637-642. DOI: 10.3928/0048-5713-19941201-07  0.544
1994 George M, Ketter T, Post R. An overview of brain activation studies in mood disorders Biological Psychiatry. 35: 658. DOI: 10.1016/0006-3223(94)90814-1  0.553
1994 Ketter T, George M, Andreason P, Herscovitch P, Post R. Blunted paralimbic resting and procaine-activated rCBF in healthy females compared to males Biological Psychiatry. 35: 648. DOI: 10.1016/0006-3223(94)90777-3  0.556
1994 George M, Ketter T, Parekh P, Post R. Regional blood flow correlates of transient self-induced sadness or happiness Biological Psychiatry. 35: 647. DOI: 10.1016/0006-3223(94)90776-5  0.477
1994 George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression Depression. 2: 59-72. DOI: 10.1002/DEPR.3050020202  0.551
1993 Margolis RL, Chuang DM, Dick D, Weiss SR, Post RM. Effect of cocaine, lidocaine kindling and carbamazepine on batrachotoxin-induced phosphoinositide hydrolysis in rat brain slices. Brain Research. 614: 185-90. PMID 8394185 DOI: 10.1016/0006-8993(93)91033-O  0.559
1993 George MS, Ketter TA, Gill DS, Haxby JV, Ungerleider LG, Herscovitch P, Post RM. Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 384-94. PMID 8286936 DOI: 10.1176/Jnp.5.4.384  0.504
1993 Post RM, Ketter TA, Pazzaglia PJ, George MS, Marangell L, Denicoff K. New developments in the use of anticonvulsants as mood stabilizers. Neuropsychobiology. 27: 132-7. PMID 8232827 DOI: 10.1159/000118968  0.529
1992 Post RM, Weiss SR, Chuang DM. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. Journal of Clinical Psychopharmacology. 12: 23S-35S. PMID 1541715 DOI: 10.1097/00004714-199202001-00005  0.517
1991 Altshuler LL, Conrad A, Hauser P, Li XM, Guze BH, Denikoff K, Tourtellotte W, Post R. Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Archives of General Psychiatry. 48: 482-3. PMID 2021303 DOI: 10.1001/Archpsyc.1991.01810290094018  0.381
1986 Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW. The corticotropin-releasing hormone stimulation test in patients with panic disorder. The American Journal of Psychiatry. 143: 896-9. PMID 3013032 DOI: 10.1176/Ajp.143.7.896  0.304
1984 Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux D(. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. American Journal of Psychiatry. 141: 619-627. PMID 6324597 DOI: 10.1176/Ajp.141.5.619  0.331
1983 Gold PW, Robertson GL, Ballenger JC, Goodwin FK, Rubinow DR, Kellner C, Post RM. Neurohypophyseal function in affective illness. Psychopharmacology Bulletin. 19: 426-31. PMID 6635117  0.384
1983 Gold PW, Robertson GL, Ballenger JC, Kaye W, Chen J, Rubinow DR, Goodwin FK, Post RM. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. The Journal of Clinical Endocrinology and Metabolism. 57: 952-7. PMID 6619270 DOI: 10.1210/Jcem-57-5-952  0.448
1983 Gold PW, Robertson GL, Post RM, Kaye W, Ballenger J, Rubinow D, Goodwin FK. The effect of lithium on the osmoregulation of arginine vasopressin secretion. The Journal of Clinical Endocrinology and Metabolism. 56: 295-9. PMID 6401749 DOI: 10.1210/jcem-56-2-295  0.446
1983 Cowdry RW, Ebert MH, van Kammen DP, Post RM, Goodwin FK. Cerebrospinal fluid probenecid studies: a reinterpretation. Biological Psychiatry. 18: 1287-99. PMID 6197100  0.39
1983 Goodwin FK, Post RM. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. British Journal of Clinical Pharmacology. 15: 393S-405S. PMID 6190490  0.442
1982 Goodwin FK, Prange AJ, Post RM, Muscettola G, Lipton MA. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. The American Journal of Psychiatry. 139: 34-8. PMID 7055275 DOI: 10.1176/AJP.139.1.34  0.645
1982 Post RM, Gold P, Rubinow DR, Ballenger JC, Bunney WE, Goodwin FK. Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sciences. 31: 1-15. PMID 6180277 DOI: 10.1016/0024-3205(82)90394-0  0.386
1981 Weingartner H, Gold P, Ballenger JC, Smallberg SA, Summers R, Rubinow DR, Post RM, Goodwin FK. Effects of vasopressin on human memory functions. Science (New York, N.Y.). 211: 601-3. PMID 7455701 DOI: 10.1126/science.7455701  0.359
1981 Jimerson DC, Ballenger JC, Lake CR, Post RM, Goodwin FK, Kopin IJ. Plasma and CSF MHPG in normals [proceedings]. Psychopharmacology Bulletin. 17: 86-7. PMID 7232666  0.489
1981 Gold PW, Goodwin FK, Post RM, Robertson GL. Vasopressin function in depression and mania [proceedings]. Psychopharmacology Bulletin. 17: 7-9. PMID 7232662  0.457
1981 Jimerson DC, Nurnberger JI, Post RM, Gershon ES, Kopin IJ. Plasma MHPG in rapid cyclers and healthy twins. Archives of General Psychiatry. 38: 1287-90. PMID 7197905 DOI: 10.1001/Archpsyc.1981.01780360103012  0.387
1981 Gillin JC, Duncan WC, Murphy DL, Post RM, Wehr TA, Goodwin FK, Wyatt RJ, Bunney WE. Age-related changes in sleep in depressed and normal subjects. Psychiatry Research. 4: 73-8. PMID 6939001 DOI: 10.1016/0165-1781(81)90010-X  0.394
1981 Naber D, Pickar D, Post RM, Van Kammen DP, Waters RN, Ballenger JC, Goodwin FK, Bunney WE. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. The American Journal of Psychiatry. 138: 1457-62. PMID 6271019 DOI: 10.1176/ajp.138.11.1457  0.45
1980 Gillin JC, Sitaram N, Duncan WC, Gershon ES, Nurnberger J, Post RM, Murphy DL, Wehr T, Goodwin FK, Bunney WE. Sleep disturbance in depression: diagnostic potential and pathophysiology [proceedings]. Psychopharmacology Bulletin. 16: 40-2. PMID 7454933  0.417
1980 Davis GC, Extein I, Reus VI, Hamilton W, Post RM, Goodwin FK, Bunney WE. Failure of naloxone to reduce manic symptoms. The American Journal of Psychiatry. 137: 1583-5. PMID 7435717  0.402
1980 Lake CR, Sternberg DE, van Kammen DP, Ballenger JC, Ziegler MG, Post RM, Kopin IJ, Bunney WE. Schizophrenia: elevated cerebrospinal fluid norepinephrine. Science (New York, N.Y.). 207: 331-3. PMID 7350667 DOI: 10.1126/Science.7350667  0.393
1980 Post RM, Jimerson DC, Bunney WE, Goodwin FK. Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology. 67: 297-305. PMID 6155678 DOI: 10.1007/Bf00431272  0.39
1979 Beckmann H, Ebert MH, Post R, Goodwin FK. Effect of moderate exercise on urinary MHPG in depressed patients. Pharmakopsychiatrie, Neuro-Psychopharmakologie. 12: 351-6. PMID 504341 DOI: 10.1055/s-0028-1094630  0.5
1979 Ballenger JC, Post RM, Sternberg DE, Van Kammen DP, Cowdry RW, Goodwin FK. Headaches after lumbar puncture and insensitivity to pain in psychiatric patients. The New England Journal of Medicine. 301: 110. PMID 449939 DOI: 10.1056/NEJM197907123010219  0.381
1979 Jimerson DC, Post RM, Carman JS, van Kammen DP, Wood JH, Goodwin FK, Bunney WE. CSF calcium: clinical correlates in affective illness and schizophrenia. Biological Psychiatry. 14: 37-51. PMID 420907  0.462
1979 Gold PW, Weingartner H, Ballenger JC, Goodwin FK, Post RM. Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder. Lancet. 2: 992-4. PMID 91778 DOI: 10.1016/S0140-6736(79)92563-7  0.487
1978 Lerner P, Goodwin FK, van Kammen DP, Post RM, Major LF, Ballenger JC, Lovenberg W. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. Biological Psychiatry. 13: 685-94. PMID 737256  0.511
1978 Post RM, Lake CR, Jimerson DC, Bunney WE, Wood JH, Ziegler MG, Goodwin FK. Cerebrospinal fluid norepinephrine in affective illness. The American Journal of Psychiatry. 135: 907-12. PMID 665831 DOI: 10.1176/AJP.135.8.907  0.515
1978 Post RM, Gerner RH, Carman JS, Gillin JC, Jimerson DC, Goodwin FK, Bunney WE. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response. Archives of General Psychiatry. 35: 609-15. PMID 215097 DOI: 10.1001/Archpsyc.1978.01770290091008  0.462
1978 Jimerson DC, Gordon EK, Post RM, Goodwin FK. Homovanillic acid in human CSF: comparison of fluorimetry and gas chromatography-mass spectrometry. Communications in Psychopharmacology. 2: 343-9. PMID 103678  0.342
1977 Carman JS, Post RM, Goodwin FK, Bunney WE. Calcium and electroconvulsive therapy of severe depressive illness. Biological Psychiatry. 12: 5-17. PMID 836923  0.472
1977 Goodwin FK, Post RM, Wehr T. Clinical approaches to the evaluation of brain amine function in mental illness: some conceptual issues. Essays in Neurochemistry and Neuropharmacology. 2: 71-104. PMID 361387  0.383
1977 Davis GC, Bunney WE, DeFraites EG, Kleinman JE, van Kammen DP, Post RM, Wyatt RJ. Intravenous naloxone administration in schizophrenia and affective illness. Science (New York, N.Y.). 197: 74-7. PMID 325650 DOI: 10.1126/SCIENCE.325650  0.347
1977 Post RM, Cramer H, Goodwin FK. Cyclic AMP in cerebrospinal fluid of manic and depressive patients. Psychological Medicine. 7: 599-605. PMID 201957  0.484
1976 Post RM, Kotin J, Goodwin FK. Effects of sleep deprivation on mood and central amine metabolism in depressed patients. Archives of General Psychiatry. 33: 627-32. PMID 1267578  0.459
1976 Jimerson DC, Post RM, Goodwin FK. Antidepressant treatments and alterations in central serotonin turnover in affective illness. Monographs in Neural Sciences. 3: 15-22. PMID 790167 DOI: 10.1159/000399329  0.436
1976 Carman JS, Post RM, Buswell R, Goodwin FK. Negative effects of melatonin on depression. The American Journal of Psychiatry. 133: 1181-6. PMID 788529  0.478
Low-probability matches (unlikely to be authored by this person)
2003 Post RM, Baldassano CF, Perlis RH, Ginsberg DL. Treatment of bipolar depression. Cns Spectrums. 8: 1-10; quiz 11. PMID 14986671 DOI: 10.1007/978-1-60327-435-7_5  0.3
1985 Uhde TW, Boulenger JP, Roy-Byrne PP, Geraci MF, Vittone BJ, Post RM. Longitudinal course of panic disorder: clinical and biological considerations. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 39-51. PMID 3991912 DOI: 10.1016/0278-5846(85)90178-2  0.299
2004 Post RM, Calabrese JR. Bipolar depression: the role of atypical antipsychotics. Expert Review of Neurotherapeutics. 4: S27-33. PMID 16279863 DOI: 10.1586/14737175.4.6.S27  0.299
1983 Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Bollinger J, Reichlin S. CSF somatostatin in affective illness. Archives of General Psychiatry. 40: 409-12. PMID 6132592 DOI: 10.1001/archpsyc.1983.01790040063009  0.297
2006 Keck PE, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biological Psychiatry. 60: 1020-2. PMID 16814257 DOI: 10.1016/J.Biopsych.2006.03.056  0.296
1985 Rubinow DR, Gold PW, Post RM, Ballenger JC. CSF somatostatin in affective illness and normal volunteers Progress in Neuropsychopharmacology and Biological Psychiatry. 9: 393-400. PMID 2866561 DOI: 10.1016/0278-5846(85)90192-7  0.294
2007 Suppes T, Kelly DI, Keck PE, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network. International Clinical Psychopharmacology. 22: 376-81. PMID 17917557 DOI: 10.1097/Yic.0B013E3281C55F63  0.294
2016 Post RM. Treatment of Bipolar Depression: Evolving Recommendations. The Psychiatric Clinics of North America. 39: 11-33. PMID 26876316 DOI: 10.1016/j.psc.2015.09.001  0.293
1992 Post RM, Ketter TA, Joffe RT, Kramlinger KL. Lack of beneficial effects of l-baclofen in affective disorder. International Clinical Psychopharmacology. 6: 197-207. PMID 1816278 DOI: 10.1097/00004850-199100640-00001  0.29
1992 Post RM, Weiss SRB. Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic Biological Psychiatry. 32: 469-484. PMID 1445965 DOI: 10.1016/0006-3223(92)90216-M  0.289
2007 Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE, McElroy SL, Grunze H, Post RM. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorders. 9: 531-5. PMID 17680925 DOI: 10.1111/J.1399-5618.2007.00467.X  0.287
1980 Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: A new treatment American Journal of Psychiatry. 137: 782-790. PMID 7386656 DOI: 10.1176/AJP.137.7.782  0.286
2003 Post RM, Speer AM, Hough CJ, Xing G. Neurobiology of bipolar illness: implications for future study and therapeutics. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 15: 85-94. PMID 12938866 DOI: 10.1023/A:1024684225114  0.286
2009 Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. The American Journal of Psychiatry. 166: 164-72. PMID 19015231 DOI: 10.1176/Appi.Ajp.2008.08030322  0.284
2002 Suppes T, Chisholm KA, Dhavale D, Frye MA, Altshuler LL, McElroy SL, Keck PE, Nolen WA, Kupka R, Denicoff KD, Leverich GS, Rush AJ, Post RM. Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disorders. 4: 283-9. PMID 12479659 DOI: 10.1034/J.1399-5618.2002.01201.X  0.284
2006 Altshuler LL, Post RM, Black DO, Keck PE, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. The Journal of Clinical Psychiatry. 67: 1551-60. PMID 17107246 DOI: 10.4088/Jcp.V67N1009  0.284
1999 Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D, Leverich GS, Post RM. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. The American Journal of Psychiatry. 156: 1909-14. PMID 10588404 DOI: 10.1176/Ajp.156.12.1909  0.283
2005 Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. The American Journal of Psychiatry. 162: 1273-80. PMID 15994709 DOI: 10.1176/Appi.Ajp.162.7.1273  0.282
2010 Drieling T, Scherer-Klabunde D, Schaerer LO, Biedermann NC, Post RM, Langosch JM. Interpersonal and Instrumental Functioning of Patients With Bipolar Disorder Depends on Remaining Depressive Symptoms German Journal of Psychiatry. 13: 61-65.  0.282
2004 Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. The American Journal of Psychiatry. 161: 1447-54. PMID 15285972 DOI: 10.1176/Appi.Ajp.161.8.1447  0.281
2007 McElroy SL, Suppes T, Frye MA, Altshuler LL, Stanford K, Martens B, Leverich GS, Post RM, Keck PE. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. Journal of Affective Disorders. 101: 275-81. PMID 17229469 DOI: 10.1016/j.jad.2006.11.025  0.28
2016 Miller S, Suppes T, Mintz J, Hellemann G, Frye MA, McElroy SL, Nolen WA, Kupka R, Leverich GS, Grunze H, Altshuler LL, Keck PE, Post RM. Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network. The American Journal of Psychiatry. appiajp201615091119. PMID 27079133 DOI: 10.1176/Appi.Ajp.2016.15091119  0.279
2002 Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. Presentations of depression in bipolar illness Clinical Neuroscience Research. 2: 142-157. DOI: 10.1016/S1566-2772(02)00039-7  0.279
2019 Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CMR, Post R. Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants. Focus (American Psychiatric Publishing). 17: 322-324. PMID 32015724 DOI: 10.1176/appi.focus.17307  0.279
1992 Bromfield EB, Altshuler L, Leiderman DB, Balish M, Ketter TA, Devinsky O, Post RM, Theodore WH. Cerebral metabolism and depression in patients with complex partial seizures. Archives of Neurology. 49: 617-23. PMID 1596197 DOI: 10.1001/Archneur.1992.00530300049010  0.278
2003 Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. The Journal of Clinical Psychiatry. 64: 680-90; quiz 738-9. PMID 12823083 DOI: 10.4088/Jcp.V64N0610  0.278
2004 Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ, Akiskal H, Allain H, Ayuso-Gutiérrez J, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois M, Burrows G, ... ... Post R, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment World Journal of Biological Psychiatry. 5: 120-135. PMID 15346536 DOI: 10.1080/15622970410029924  0.278
2003 Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disorders. 5: 310-9. PMID 14525551 DOI: 10.1034/J.1399-5618.2003.00051.X  0.277
1984 Boulenger JP, Uhde TW, Wolff EA, Post RM. Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Archives of General Psychiatry. 41: 1067-71. PMID 6497568 DOI: 10.1001/Archpsyc.1983.01790220057009  0.277
1986 Roy-Byrne PP, Uhde TW, Post RM. Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Archives of General Psychiatry. 43: 895-9. PMID 3753167 DOI: 10.1001/Archpsyc.1986.01800090085011  0.276
2000 McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biological Psychiatry. 47: 1025-33. PMID 10862801 DOI: 10.1016/S0006-3223(99)00316-9  0.275
1992 Mellman TA, Leverich GS, Hauser P, Kramlinger K, Post RM, Uhde TW. Axis II pathology in panic and affective disorders: Relationship to diagnosis, course of illness, and treatment response Journal of Personality Disorders. 6: 53-63.  0.275
2008 Zhang ZJ, Tan QR, Tong Y, Li Q, Kang WH, Zhen XC, Post RM. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study. Journal of Affective Disorders. 109: 91-7. PMID 18093662 DOI: 10.1016/j.jad.2007.11.004  0.274
1985 Joffe RT, Post RM, Roy-Byrne PP, Uhde TW. Hematological effects of carbamazepine in patients with affective illness. The American Journal of Psychiatry. 142: 1196-9. PMID 4037133 DOI: 10.1176/AJP.142.10.1196  0.274
1995 Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. The American Journal of Psychiatry. 152: 1130-8. PMID 7625459 DOI: 10.1176/AJP.152.8.1130  0.271
1981 Cutler NR, Post RM, Rey AC, Bunney WE. Depression-dependent dyskinesias in two cases of manic-depressive illness. The New England Journal of Medicine. 304: 1088-9. PMID 7207567 DOI: 10.1056/Nejm198104303041807  0.271
1993 Gill DS, Ketter TA, Post RM. Antidepressant response to sleep deprivation as a function of time into depressive episode in rapidly cycling bipolar patients. Acta Psychiatrica Scandinavica. 87: 102-9. PMID 8447235 DOI: 10.1111/j.1600-0447.1993.tb03338.x  0.271
2016 Post R, Leverich G, Kupka R, McElroy S, Altshuler L, Frye M, Rowe M, Grunze H, Suppes T, Keck P, Nolen W, Findling R. Four generations of US patients are more ill than those from the Netherlands and Germany F1000research. 5. DOI: 10.7490/F1000Research.1111960.1  0.27
1994 Baptista T, Weiss SRB, Zocchi A, Sitcoske M, Post R. Electrical kindling is associated with increases in amygdala acetylcholine levels: an in vivo microdialysis study Neuroscience Letters. 167: 133-136. PMID 8177511 DOI: 10.1016/0304-3940(94)91045-6  0.269
2003 Keck PE, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Comprehensive Psychiatry. 44: 263-9. PMID 12923703 DOI: 10.1016/S0010-440X(03)00089-0  0.268
1996 Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M. Rational polypharmacy in the bipolar affective disorders. Epilepsy Research. Supplement. 11: 153-80. PMID 9294735  0.267
2007 Nolen WA, Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, Suppes T, Keck PE, McElroy S, Grunze H, Mintz J, Post RM. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatrica Scandinavica. 115: 360-5. PMID 17430413 DOI: 10.1111/J.1600-0447.2007.00993.X  0.266
2000 Speer AM, Kimbrell TA, Wassermann EM, D Repella J, Willis MW, Herscovitch P, Post RM. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry. 48: 1133-41. PMID 11137053 DOI: 10.1016/S0006-3223(00)01065-9  0.265
1986 Joffe RT, Post RM, Ballenger JC, Rebar R, Gold PW. The effects of lithium on neuroendocrine function in affectively ill patients. Acta Psychiatrica Scandinavica. 73: 524-8. PMID 3092580 DOI: 10.1111/j.1600-0447.1986.tb02720.x  0.264
1988 Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder American Journal of Psychiatry. 145: 1104-1109. PMID 3046381 DOI: 10.1176/Ajp.145.9.1104  0.264
1991 Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. The Journal of Clinical Endocrinology and Metabolism. 72: 260-71. PMID 1846869 DOI: 10.1210/jcem-72-2-260  0.264
1980 Savard RJ, Rey AC, Post RM. Halstead-Reitan Category Test in bipolar and unipolar affective disorders. Relationship to age and phase of illness. The Journal of Nervous and Mental Disease. 168: 297-304. PMID 7365494 DOI: 10.1097/00005053-198005000-00010  0.263
2014 Post RM, Ostacher MJ, Singh V. Controversies in the psychopharmacology of bipolar disorder. The Journal of Clinical Psychiatry. 75: e30. PMID 25470106 DOI: 10.4088/JCP.13095tx2cj  0.263
2012 Bücker J, Kapczinski F, Post R, Ceresér KM, Szobot C, Yatham LN, Kapczinski NS, Kauer-Sant'Anna M. Cognitive impairment in school-aged children with early trauma. Comprehensive Psychiatry. 53: 758-64. PMID 22300905 DOI: 10.1016/J.Comppsych.2011.12.006  0.262
2005 Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW, Luckenbaugh DA, Post RM. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biological Psychiatry. 57: 220-8. PMID 15691522 DOI: 10.1016/J.Biopsych.2004.10.033  0.262
1985 Uhde TW, Bierer LM, Post RM. Caffeine-induced escape from dexamethasone suppression. Archives of General Psychiatry. 42: 737-8. PMID 3893356 DOI: 10.1001/Archpsyc.1985.01790300105014  0.261
2002 Dunn RT, Kimbrell TA, Ketter TA, Frye MA, Willis MW, Luckenbaugh DA, Post RM. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biological Psychiatry. 51: 387-99. PMID 11904133 DOI: 10.1016/S0006-3223(01)01244-6  0.261
2005 McElroy SL, Suppes T, Keck PE, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. The Journal of Clinical Psychiatry. 66: 617-24. PMID 15889949 DOI: 10.4088/Jcp.V66N0512  0.26
1989 Post RM, Jimerson DC, Bunney WE. Perspectives in the treatment of the psychoneurological disorders: affective disorders. Progress in Neuro-Psychopharmacology. 3: 65-74. PMID 45566 DOI: 10.1016/0364-7722(79)90071-7  0.26
1999 Goldstein TR, Frye MA, Denicoff KD, Smith-Jackson E, Leverich GS, Bryan AL, Ali SO, Post RM. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. The Journal of Clinical Psychiatry. 60: 563-7; quiz 568-9. PMID 10485646  0.259
1984 Siever LJ, Uhde TW, Jimerson DC, Post RM, Lake CR, Murphy DL. Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Archives of General Psychiatry. 41: 63-8. PMID 6691786 DOI: 10.1001/Archpsyc.1984.01790120067009  0.258
2005 Post RM. Adjunctive strategies in the treatment of refractory bipolar depression: clinician options in the absence of a systematic database. Expert Opinion On Pharmacotherapy. 6: 531-46. PMID 15934880 DOI: 10.1517/14656566.6.4.531  0.258
2005 Dunn RT, Willis MW, Benson BE, Repella JD, Kimbrell TA, Ketter TA, Speer AM, Osuch EA, Post RM. Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Research. 140: 181-98. PMID 16257515 DOI: 10.1016/J.Pscychresns.2005.07.005  0.258
2007 Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. The American Journal of Psychiatry. 164: 1242-9. PMID 17671288 DOI: 10.1176/appi.ajp.2007.06060981  0.257
1997 Post RM, Leverich GS, Denicoff KD, Frye MA, Kimbrell TA, Dunn R. Alternative approaches to refractory depression in bipolar illness. Depression and Anxiety. 5: 175-89. PMID 9338110 DOI: 10.1002/(SICI)1520-6394(1997)5:4<175::AID-DA4>3.0.CO;2-C  0.256
1992 Rubinow DR, Post RM. Impaired recognition of affect in facial expression in depressed patients Biological Psychiatry. 31: 947-953. PMID 1637932 DOI: 10.1016/0006-3223(92)90120-O  0.256
1986 Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Antidepressant effects of carbamazepine. The American Journal of Psychiatry. 143: 29-34. PMID 3510572 DOI: 10.1176/Ajp.143.1.29  0.256
2008 Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biological Psychiatry. 63: 125-30. PMID 17543894 DOI: 10.1016/j.biopsych.2006.12.031  0.255
2007 Post RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research. 41: 979-90. PMID 17239400 DOI: 10.1016/j.jpsychires.2006.09.009  0.254
2014 Speer AM, Wassermann EM, Benson BE, Herscovitch P, Post RM. Antidepressant efficacy of high and low frequency rTMS at 110% of motor threshold versus sham stimulation over left prefrontal cortex. Brain Stimulation. 7: 36-41. PMID 23928104 DOI: 10.1016/j.brs.2013.07.004  0.254
1987 Uhde TW, Berrettini WH, Roy-Byrne PP, Boulenger JP, Post RM. Platelet [3H]imipramine binding in patients with panic disorder. Biological Psychiatry. 22: 52-8. PMID 3790640 DOI: 10.1016/0006-3223(87)90129-6  0.254
1979 Gerner RH, Post RM, Gillin JC, Bunney WE. Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. Journal of Psychiatric Research. 15: 21-40. PMID 219193 DOI: 10.1016/0022-3956(79)90004-9  0.254
2000 Brotman MA, Fergus EL, Post RM, Leverich GS. High exposure to neuroleptics in bipolar patients: a retrospective review. The Journal of Clinical Psychiatry. 61: 68-72; quiz 73. PMID 10695653 DOI: 10.4088/Jcp.V61N0116  0.254
2007 Post RM, Ketter TA, Uhde T, Ballenger JC. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. Cns Drugs. 21: 47-71. PMID 17190529 DOI: 10.2165/00023210-200721010-00005  0.253
1977 Post RM, Stoddard FJ, Gillin JC, Buchsbaum MS, Runkle DC, Black KE, Bunney WE. Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient. Archives of General Psychiatry. 34: 470-7. PMID 192169 DOI: 10.1001/Archpsyc.1977.01770160104009  0.253
1999 Suppes T, Brown ES, McElroy SL, Keck PE, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM. Lamotrigine for the treatment of bipolar disorder: a clinical case series. Journal of Affective Disorders. 53: 95-8. PMID 10363672 DOI: 10.1016/S0165-0327(98)00077-9  0.252
2004 Xing GQ, Russell S, Webster MJ, Post RM. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 143-53. PMID 14741058 DOI: 10.1017/S1461145703004000  0.252
1977 Stoddard FJ, Post RM, Bunney WE. Slow and rapid psychobiological alterations in a manic-depressive patient: clinical phenomenology. The British Journal of Psychiatry : the Journal of Mental Science. 130: 72-8. PMID 831912 DOI: 10.1192/Bjp.130.1.72  0.252
2000 Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. The Journal of Clinical Psychiatry. 61: 9-15. PMID 10695639 DOI: 10.4088/JCP.V61N0104  0.252
2002 Denicoff KD, Ali SO, Sollinger AB, Smith-Jackson EE, Leverich GS, Post RM. Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder. Depression and Anxiety. 15: 1-9. PMID 11816046 DOI: 10.1002/da.1078  0.252
1973 Post RM, Gordon EK, Goodwin FK, Bunney WE. Central norepinephrine metabolism in affective illness: MHPG in the cerebrospinal fluid. Science (New York, N.Y.). 179: 1002-3. PMID 4687583 DOI: 10.1126/Science.179.4077.1002  0.251
1993 Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology. 57: 79-88. PMID 8097579 DOI: 10.1159/000126345  0.251
2018 Post RM, McElroy S, Kupka R, Suppes T, Hellemann G, Nolen W, Frye M, Keck P, Grunze H, Rowe M. Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder. The Journal of Nervous and Mental Disease. PMID 29781886 DOI: 10.1097/Nmd.0000000000000819  0.251
1987 Kellner CH, Post RM, Putnam F, Cowdry R, Gardner D, Kling MA, Minichiello MD, Trettau JR, Coppola R. Intravenous procaine as a probe of limbic system activity in psychiatric patients and normal controls. Biological Psychiatry. 22: 1107-26. PMID 2820518 DOI: 10.1016/0006-3223(87)90053-9  0.25
1986 Rubinow DR, Post RM, Gold PW, Uhde TW. Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness Psychopharmacology. 88: 115-118. PMID 3080769 DOI: 10.1007/Bf00310525  0.249
2009 Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. The Journal of Clinical Psychiatry. 70: 450-7. PMID 19358785 DOI: 10.4088/Jcp.08M04191  0.249
2001 Ali SO, Denicoff KD, Altshuler LL, Hauser P, Li X, Conrad AJ, Smith-Jackson EE, Leverich GS, Post RM. Relationship between prior course of illness and neuroanatomic structures in bipolar disorder: a preliminary study. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 14: 227-32. PMID 11725216  0.248
1986 Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. The New England Journal of Medicine. 314: 1329-35. PMID 3010108 DOI: 10.1056/NEJM198605223142101  0.248
2005 Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE, Nolen WA, Leverich GS, Grunze H, Rush AJ, Post RM. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Archives of General Psychiatry. 62: 1089-96. PMID 16203954 DOI: 10.1001/Archpsyc.62.10.1089  0.248
1985 Post RM, Rubinow DR, Uhde TW, Ballenger JC, Lake CR, Linnoila M, Jimerson DC, Reus V. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology. 87: 59-63. PMID 2997829 DOI: 10.1007/Bf00431779  0.248
2010 Post RM, Leverich GS, Kupka RW, Keck PE, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. The Journal of Clinical Psychiatry. 71: 864-72. PMID 20667291 DOI: 10.4088/Jcp.08M04994Yel  0.247
1981 Post RM, Ballenger JC, Rey AC, Bunney WE. Slow and rapid onset of manic episodes: implications for underlying biology. Psychiatry Research. 4: 229-37. PMID 6939012 DOI: 10.1016/0165-1781(81)90025-1  0.247
2015 Post RM. Relative absence of studies in bipolar depression. International Clinical Psychopharmacology. 30: 239-40. PMID 26230177 DOI: 10.1097/YIC.0000000000000083  0.247
2003 Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. The Journal of Clinical Psychiatry. 64: 1483-94. PMID 14728111 DOI: 10.4088/Jcp.V64N1213  0.246
2004 Suppes T, McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, Leverich GS, Nolen WA, Chisholm K, Dennehy EB, Post RM. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. International Clinical Psychopharmacology. 19: 173-4. PMID 15107662 DOI: 10.1097/00004850-200405000-00010  0.246
2012 Soeiro-de-Souza MG, Post RM, de Sousa ML, Missio G, do Prado CM, Gattaz WF, Moreno RA, Machado-Vieira R. Does BDNF genotype influence creative output in bipolar I manic patients? Journal of Affective Disorders. 139: 181-6. PMID 22484201 DOI: 10.1016/J.Jad.2012.01.036  0.245
1989 Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, Cowdry R. Dysphoric mania. Clinical and biological correlates. Archives of General Psychiatry. 46: 353-8. PMID 2930331 DOI: 10.1001/archpsyc.1989.01810040059009  0.245
2018 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, ... ... Post RM, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. PMID 29536616 DOI: 10.1111/Bdi.12609  0.245
1985 Jimerson DC, Cutler NR, Post RM, Rey A, Gold PW, Brown GM, Bunney WE. Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects. Psychiatry Research. 13: 1-12. PMID 6595680 DOI: 10.1016/0165-1781(84)90113-6  0.245
1985 Joffe RT, Blank DW, Post RM, Uhde TW. Decreased triiodothyronines in depression: a preliminary report. Biological Psychiatry. 20: 922-5. PMID 4027305 DOI: 10.1016/0006-3223(85)90218-5  0.244
1997 De Vry J, Fritze J, Post RM. The management of coexisting depression in patients with dementia: potential of calcium channel antagonists. Clinical Neuropharmacology. 20: 22-35. PMID 9037570 DOI: 10.1097/00002826-199702000-00003  0.243
2018 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Nolen WA. More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring. European Archives of Psychiatry and Clinical Neuroscience. PMID 30099616 DOI: 10.1007/S00406-018-0934-Y  0.242
2001 Osuch EA, Cora-Locatelli G, Frye MA, Huggins T, Kimbrell TA, Ketter TA, Callahan AM, Post RM. Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. Acta Psychiatrica Scandinavica. 104: 397-401. PMID 11722323 DOI: 10.1034/j.1600-0447.2001.00395.x  0.242
2006 Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. The American Journal of Psychiatry. 163: 232-9. PMID 16449476 DOI: 10.1176/Appi.Ajp.163.2.232  0.242
2000 Post RM, Speer AM, Weiss SR, Li H. Seizure models: anticonvulsant effects of ECT and rTMS. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 1251-73. PMID 11125852 DOI: 10.1016/S0278-5846(00)00138-X  0.242
1986 Joffe RT, Post RM, Ballenger JC, Rebar R, Gold PW. Neuroendocrine effects of carbamazepine in patients with affective illness. Epilepsia. 27: 156-60. PMID 3082622 DOI: 10.1111/j.1528-1157.1986.tb03519.x  0.242
2021 Post RM, Grunze H. The Challenges of Children with Bipolar Disorder. Medicina (Kaunas, Lithuania). 57. PMID 34207966 DOI: 10.3390/medicina57060601  0.242
2001 McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. The American Journal of Psychiatry. 158: 420-6. PMID 11229983 DOI: 10.1176/Appi.Ajp.158.3.420  0.241
1983 Post RM, Uhde TW, Ballenger JC, Squillace KM. Prophylactic efficacy of carbamazepine in manic-depressive illness American Journal of Psychiatry. 140: 1602-1604. PMID 6139957 DOI: 10.1176/AJP.140.12.1602  0.241
1986 Roy-Byrne PP, Uhde TW, Rubinow DR, Post RM. Reduced TSH and prolactin responses to TRH in patients with panic disorder American Journal of Psychiatry. 143: 503-507. PMID 3082224 DOI: 10.1176/Ajp.143.4.503  0.24
2016 Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Comprehensive Psychiatry. 66: 146-156. PMID 26995248 DOI: 10.1016/J.Comppsych.2016.01.009  0.239
2017 Post RM. The New News About Lithium: An Underutilized Treatment in The United States. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28976944 DOI: 10.1038/npp.2017.238  0.239
2013 Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185  0.239
1981 Rubinow DR, Post RM, Pickar D, Naber D, Ballenger JC, Gold PW, Bunney WE. Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers. Psychiatry Research. 5: 87-93. PMID 6269142 DOI: 10.1016/0165-1781(81)90064-0  0.239
1995 Smith M, Makino S, Kvetnansky R, Post R. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus The Journal of Neuroscience. 15: 1768-1777. DOI: 10.1523/JNEUROSCI.15-03-01768.1995  0.238
1974 Post RM, Goodwin FK. Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients. Archives of General Psychiatry. 30: 234-9. PMID 4809930 DOI: 10.1001/ARCHPSYC.1974.01760080082014  0.238
2001 Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders. 67: 45-59. PMID 11869752  0.238
1986 Joffe RT, Blank DW, Berrettini WH, Post RM. Erythrocyte sodium and potassium in affective illness. Acta Psychiatrica Scandinavica. 73: 416-9. PMID 3728068 DOI: 10.1111/j.1600-0447.1986.tb02705.x  0.238
2002 Xing G, Chavko M, Zhang LX, Yang S, Post RM. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophrenia Research. 58: 21-30. PMID 12363386 DOI: 10.1016/S0920-9964(01)00388-7  0.237
1992 Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. The American Journal of Psychiatry. 149: 999-1010. PMID 1353322 DOI: 10.1176/AJP.149.8.999  0.237
1984 POST RM, BERRETTINI W, UHDE TW, KELLNER C. Selective Response to the Anticonvulsant Carbamazepine in Manic-Depressive Illness Journal of Clinical Psychopharmacology. 4: 178???185. DOI: 10.1097/00004714-198408000-00002  0.237
1982 Davis GC, Buchsbaum MS, Naber D, Pickar D, Post R, van Kammen D, Bunney WE. Altered pain perception and cerebrospinal endorphins in psychiatric illness. Annals of the New York Academy of Sciences. 398: 366-73. PMID 6961863 DOI: 10.1111/J.1749-6632.1982.Tb39507.X  0.237
2000 Little JT, Kimbrell TA, Wassermann EM, Grafman J, Figueras S, Dunn RT, Danielson A, Repella J, Huggins T, George MS, Post RM. Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 13: 119-24. PMID 10780630  0.237
1997 Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Research. 73: 159-71. PMID 9481807 DOI: 10.1016/S0165-1781(97)00123-6  0.237
2001 Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders. 3: 259-65. PMID 11912569 DOI: 10.1034/J.1399-5618.2001.30505.X  0.236
1986 Joffe RT, Post RM, Uhde TW. Effects of carbamazepine on serum electrolytes in affectively ill patients. Psychological Medicine. 16: 331-5. PMID 3726007 DOI: 10.1017/S0033291700009144  0.236
2003 Ketter TA, Manji HK, Post RM. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. Journal of Clinical Psychopharmacology. 23: 484-95. PMID 14520126 DOI: 10.1097/01.jcp.0000088915.02635.e8  0.236
1995 Pazzaglia PJ, Post RM, Rubinow D, Kling MA, Huggins TS, Sunderland T. Cerebrospinal fluid total protein in patients with affective disorders. Psychiatry Research. 57: 259-66. PMID 7501736 DOI: 10.1016/0165-1781(95)02704-Z  0.236
2003 Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. The Journal of Clinical Psychiatry. 64: 506-15. PMID 12755652 DOI: 10.4088/Jcp.V64N0503  0.235
2008 Shivakumar G, Bernstein IH, Suppes T, Keck PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Post RM. Are bipolar mood symptoms affected by the phase of the menstrual cycle? Journal of Women's Health (2002). 17: 473-8. PMID 18328012 DOI: 10.1089/Jwh.2007.0466  0.235
2011 McElroy SL, Frye MA, Hellemann G, Altshuler L, Leverich GS, Suppes T, Keck PE, Nolen WA, Kupka R, Post RM. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. Journal of Affective Disorders. 128: 191-8. PMID 20674033 DOI: 10.1016/J.Jad.2010.06.037  0.234
1976 Smith CC, Tallman JF, Post RM, van Kammen DP, Jimerson DC, Brown GL. An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients. Life Sciences. 19: 131-6. PMID 940431 DOI: 10.1016/0024-3205(76)90383-0  0.234
1983 Post RM, Uhde TW, Rubinow DR, Ballenger JC, Gold PW. Biochemical effects of carbamazepine: Relationship to its mechanisms of action in affective illness Progress in Neuropsychopharmacology and Biological Psychiatry. 7: 263-271. PMID 6137029 DOI: 10.1016/0278-5846(83)90116-1  0.234
1983 Silberman EK, Weingartner H, Post RM. Thinking disorder in depression. Archives of General Psychiatry. 40: 775-80. PMID 6860078 DOI: 10.1001/ARCHPSYC.1983.01790060073009  0.234
1984 Roy-Byrne P, Uhde TW, Post RM, Joffe RT. Relationship of response to sleep deprivation and carbamazepine in depressed patients. Acta Psychiatrica Scandinavica. 69: 379-82. PMID 6730993 DOI: 10.1111/j.1600-0447.1984.tb02508.x  0.234
2022 McIntyre RS, Alda M, Baldessarini RJ, Bauer M, Berk M, Correll CU, Fagiolini A, Fountoulakis K, Frye MA, Grunze H, Kessing LV, Miklowitz DJ, Parker G, Post RM, Swann AC, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 21: 364-387. PMID 36073706 DOI: 10.1002/wps.20997  0.234
2021 Born C, Grunze H, Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Suppes T, Keck PE, Nolen WA, Schaerer L. Mania and bipolar depression: complementing not opposing poles-a post-hoc analysis of mixed features in manic and hypomanic episodes. International Journal of Bipolar Disorders. 9: 36. PMID 34782957 DOI: 10.1186/s40345-021-00241-5  0.234
1999 Denicoff KD, Ali SO, Mirsky AF, Smith-Jackson EE, Leverich GS, Duncan CC, Connell EG, Post RM. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. Journal of Affective Disorders. 56: 67-73. PMID 10626782 DOI: 10.1016/S0165-0327(99)00028-2  0.233
2005 Swann AC, Geller B, Post RM, Altshuler L, Chang KD, Delbello MP, Reist C, Juster IA. Practical Clues to Early Recognition of Bipolar Disorder: A Primary Care Approach. Primary Care Companion to the Journal of Clinical Psychiatry. 7: 15-21. PMID 15841189 DOI: 10.4088/Pcc.V07N0103  0.233
1987 Kling MA, Kellner CH, Post RM, Cowdry RW, Gardner DL, Coppola R, Putnam FW, Gold PW. Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: Relevance to the pathophysiology of affective dysregulation in psychiatric disorders Progress in Neuropsychopharmacology and Biological Psychiatry. 11: 459-481. PMID 2827235 DOI: 10.1016/0278-5846(87)90016-9  0.232
1981 Silberman EK, Reus VI, Jimerson DC, Lynott AM, Post RM. Heterogeneity of amphetamine response in depressed patients. The American Journal of Psychiatry. 138: 1302-7. PMID 7027810 DOI: 10.1176/AJP.138.10.1302  0.232
2006 Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA. The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. Cns Spectrums. 11: 788-99. PMID 17008822 DOI: 10.1017/S1092852900014917  0.232
1973 Kotin J, Post RM, Goodwin FK. 9 -Tetrahydrocannabinol in depressed patients. Archives of General Psychiatry. 28: 345-8. PMID 4569675 DOI: 10.1001/ARCHPSYC.1973.01750330041007  0.232
2012 Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. Journal of Psychiatric Research. 46: 561-73. PMID 22444599 DOI: 10.1016/J.Jpsychires.2012.02.004  0.232
1988 Rubinow DR, Davis CL, Post RM. Somatostatin in neuropsychiatric disorders Progress in Neuropsychopharmacology and Biological Psychiatry. 12. PMID 2907936 DOI: 10.1016/0278-5846(88)90077-2  0.232
2002 Post RM, Speer AM, Obrocea GV, Leverich GS. Acute and prophylactic effects of anticonvulsants in bipolar depression Clinical Neuroscience Research. 2: 228-251. DOI: 10.1016/S1566-2772(02)00047-6  0.232
1985 DeJong R, Rubinow DR, Roy-Byrne P, Hoban MC, Grover GN, Post RM. Premenstrual mood disorder and psychiatric illness. The American Journal of Psychiatry. 142: 1359-61. PMID 4061696 DOI: 10.1176/ajp.142.11.1359  0.231
2016 Cakir S, Yazıcı O, Post RM. Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation study. Psychiatry Research. 247: 305-309. PMID 27974284 DOI: 10.1016/j.psychres.2016.11.046  0.231
2003 Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disorders. 5: 396-406. PMID 14636363 DOI: 10.1046/J.1399-5618.2003.00065.X  0.23
1982 Cutler NR, Post RM. Life course of illness in untreated manic-depressive patients. Comprehensive Psychiatry. 23: 101-15. PMID 7067425 DOI: 10.1016/0010-440X(82)90055-4  0.23
2012 Biernacka JM, McElroy SL, Crow S, Sharp A, Benitez J, Veldic M, Kung S, Cunningham JM, Post RM, Mrazek D, Frye MA. Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. Journal of Affective Disorders. 136: e21-9. PMID 21680025 DOI: 10.1016/j.jad.2011.05.038  0.23
2003 Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, Post RM, Drexhage HA. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biological Psychiatry. 53: 157-65. PMID 12547472 DOI: 10.1016/S0006-3223(02)01452-X  0.229
1989 Hauser P, Altshuler LL, Berrettini W, Dauphinais ID, Gelernter J, Post RM. Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. The Journal of Neuropsychiatry and Clinical Neurosciences. 1: 128-34. PMID 2521053 DOI: 10.1176/JNP.1.2.128  0.228
1998 Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Corá-Locatelli G, Post RM. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. Journal of Affective Disorders. 48: 91-104. PMID 9543198 DOI: 10.1016/S0165-0327(97)00160-2  0.228
1985 Wolff EA, Putnam FW, Post RM. Motor Activity and Affective Illness: The Relationship of Amplitude and Temporal Distribution to Changes in Affective State Archives of General Psychiatry. 42: 288-294. PMID 3977548 DOI: 10.1001/archpsyc.1985.01790260086010  0.228
1997 Post RM, Kimbrell TA, McCann U, Dunn RT, George MS, Weiss SR. [Are convulsions necessary for the antidepressive effect of electroconvulsive therapy: outcome of repeated transcranial magnetic stimulation]. L'EncéPhale. 23: 27-35. PMID 9333558  0.228
2007 Leverich GS, Post RM, Keck PE, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D. The poor prognosis of childhood-onset bipolar disorder. The Journal of Pediatrics. 150: 485-90. PMID 17452221 DOI: 10.1016/J.Jpeds.2006.10.070  0.228
1988 Uhde TW, Joffe RT, Jimerson DC, Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biological Psychiatry. 23: 575-85. PMID 2833321 DOI: 10.1016/0006-3223(88)90004-2  0.227
2011 Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. International Clinical Psychopharmacology. 26: 96-106. PMID 21178634 DOI: 10.1097/Yic.0B013E3283409419  0.227
2001 Kupka RW, Nolen WA, Altshuler LL, Denicoff KD, Frye MA, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Post RM. The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. The British Journal of Psychiatry. Supplement. 41: s177-83. PMID 11450180 DOI: 10.1192/Bjp.178.41.S177  0.227
2000 Denicoff KD, Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, Suppes T, Altshuler LL, Kupka R, Frye MA, Hatef J, Brotman MA, Post RM. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychological Medicine. 30: 1391-7. PMID 11097079 DOI: 10.1017/S0033291799002810  0.227
2003 Geracioti TD, Kling MA, Post RM, Gold PW. Antithyroid antibody-linked symptoms in borderline personality disorder. Endocrine. 21: 153-8. PMID 12897379 DOI: 10.1385/ENDO:21:2:153  0.226
2004 Post RM, Janicak PG, DelBello MP, Ginsberg DL. Treatment of Bipolar Mania Cns Spectrums. 9: 1-7. DOI: 10.1017/S1092852900027139  0.226
1987 Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biological Psychiatry. 22: 545-53. PMID 3495297 DOI: 10.1016/0006-3223(87)90182-X  0.226
2010 Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. The Journal of Clinical Psychiatry. 71: 1176-86; quiz 1252-3. PMID 20923622 DOI: 10.4088/Jcp.08M04811Yel  0.226
1984 Rubinow DR, Post RM, Savard R, Gold PW. Cortisol Hypersecretion and Cognitive Impairment in Depression Archives of General Psychiatry. 41: 279-283. PMID 6703846 DOI: 10.1001/archpsyc.1984.01790140069008  0.226
2001 Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, Denicoff KD, Suppes T, Altshuler LL, Kupka R, Kramlinger KG, Post RM. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. Journal of Affective Disorders. 67: 33-44. PMID 11869751 DOI: 10.1016/S0165-0327(01)00430-X  0.225
1983 Silberman EK, Weingartner H, Laraia M, Byrnes S, Post RM. Processing of emotional properties of stimuli by depressed and normal subjects. The Journal of Nervous and Mental Disease. 171: 10-4. PMID 6848642 DOI: 10.1097/00005053-198301000-00003  0.224
2020 Post RM, Leverich GS, McElroy S, Kupka R, Suppes T, Altshuler L, Nolen W, Frye M, Keck P, Grunze H, Rowe M. Relationship of comorbid personality disorders to prospective outcome in bipolar disorder. Journal of Affective Disorders. 276: 147-151. PMID 32697693 DOI: 10.1016/J.Jad.2020.07.031  0.224
2000 Post RM, Frye MA, Denicoff KD, Leverich GS, Dunn RT, Osuch EA, Speer AM, Obrocea G, Jajodia K. Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review. Bipolar Disorders. 2: 305-15. PMID 11252642 DOI: 10.1034/J.1399-5618.2000.020403.X  0.223
1997 Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. The British Journal of Psychiatry : the Journal of Mental Science. 168: 314-23. PMID 8833685 DOI: 10.1192/BJP.168.3.314  0.221
1998 McElroy SL, Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, Suppes T, Keck PE, Leverich GS, Kmetz GF, Post RM. Olanzapine in treatment-resistant bipolar disorder. Journal of Affective Disorders. 49: 119-22. PMID 9609675 DOI: 10.1016/S0165-0327(98)00002-0  0.221
2000 Hauser P, Matochik J, Altshuler LL, Denicoff KD, Conrad A, Li X, Post RM. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. Journal of Affective Disorders. 60: 25-32. PMID 10940444 DOI: 10.1016/S0165-0327(99)00154-8  0.221
2007 Levander E, Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM. Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. Journal of Affective Disorders. 101: 211-7. PMID 17254638 DOI: 10.1016/J.Jad.2006.11.023  0.22
1986 Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorders. 10: 137-52. PMID 2941470 DOI: 10.1016/0165-0327(86)90036-4  0.22
2001 Speer AM, Repella JD, Figueras S, Demian NK, Kimbrell TA, Wasserman EM, Post RM. Lack of adverse cognitive effects of 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression. The Journal of Ect. 17: 259-63. PMID 11731727  0.22
2000 Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology. 20: 607-14. PMID 11106131 DOI: 10.1097/00004714-200012000-00004  0.22
2021 Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vasquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, ... ... Post R, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disorders. PMID 34599629 DOI: 10.1111/bdi.13135  0.219
1998 Kelly K, Elger C, Bauer J, Weiss S, Post R, Walden J, Normann C, Langosch J, Berger M, Grunze H, Grunze H, Dittert S, Bungert M, Erfurth A, Amann B, ... ... Post RM, et al. Author and Subject Index Neuropsychobiology. 38: 206-206. DOI: 10.1159/000026541  0.219
1999 Little JT, Ketter TA, Mathé AA, Frye MA, Luckenbaugh D, Post RM. Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biological Psychiatry. 45: 285-9. PMID 10023503 DOI: 10.1016/S0006-3223(98)00078-X  0.219
1990 Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2: 241-54. PMID 2610821 DOI: 10.1016/0893-133x(89)90028-6  0.218
2015 Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA. Increases in multiple psychiatric disorders in parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany. Psychiatric Genetics. PMID 26146875 DOI: 10.1097/Ypg.0000000000000093  0.218
2006 Post RM, Findling RL, Kowatch RA. Earlier recognition and treatment of prepubertal-onset bipolar disorder Psychiatric Annals. 36: 630-636. DOI: 10.3928/00485713-20060901-01  0.218
1984 Uhde TW, Roy-Byrne P, Gillin JC, Mendelson WB, Boulenger JP, Vittone BJ, Post RM. The sleep of patients with panic disorder: a preliminary report. Psychiatry Research. 12: 251-9. PMID 6593756 DOI: 10.1016/0165-1781(84)90030-1  0.217
2018 Post RM, Leverich GS, McElroy S, Kupka R, Suppes T, Altshuler L, Nolen W, Frye M, Keck P, Grunze H, Hellemann G. Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state. Bipolar Disorders. PMID 29369448 DOI: 10.1111/Bdi.12596  0.217
2017 Riemann G, Weisscher N, Post RM, Altshuler L, McElroy S, Frye MA, Keck PE, Leverich GS, Suppes T, Grunze H, Nolen WA, Kupka RW. The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder. International Journal of Bipolar Disorders. 5: 31. PMID 28944443 DOI: 10.1186/S40345-017-0100-X  0.217
1984 Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry. 41: 1159-66. PMID 6334502 DOI: 10.1001/archpsyc.1984.01790230045007  0.216
1983 Silberman EK, Weingartner H, Stillman R, Chen HJ, Post RM. Altered lateralization of cognitive processes in depressed women. The American Journal of Psychiatry. 140: 1340-4. PMID 6624967 DOI: 10.1176/AJP.140.10.1340  0.216
2013 Post RM, Altshuler L, Leverich G, Nolen W, Kupka R, Grunze H, Frye M, Suppes T, McElroy S, Keck P, Rowe M. More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany. Psychiatry Research. 210: 880-6. PMID 24021999 DOI: 10.1016/J.Psychres.2013.08.007  0.216
2005 Yatham LN, Goldstein JM, Vieta E, Bowden CL, Grunze H, Post RM, Suppes T, Calabrese JR. Atypical antipsychotics in bipolar depression: potential mechanisms of action. The Journal of Clinical Psychiatry. 66: 40-8. PMID 16038601  0.215
1973 Gordon EK, Oliver J, Goodwin FK, Chase TN, Post RM. Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid. Neuropharmacology. 12: 391-6. PMID 4703880 DOI: 10.1016/0028-3908(73)90099-3  0.215
2000 Rush AJ, Post RM, Nolen WA, Keck PE, Suppes T, Altshuler L, McElroy SL. Methodological issues in developing new acute treatments for patients with bipolar illness. Biological Psychiatry. 48: 615-24. PMID 11018232 DOI: 10.1016/S0006-3223(00)00898-2  0.215
2010 Quarantini LC, Miranda-Scippa A, Nery-Fernandes F, Andrade-Nascimento M, Galvão-de-Almeida A, Guimarães JL, Teles CA, Netto LR, Lira SB, de Oliveira IR, Post RM, Kapczinski F, Koenen KC. The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. Journal of Affective Disorders. 123: 71-6. PMID 19732957 DOI: 10.1016/J.Jad.2009.08.005  0.214
2015 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. More illness in offspring of bipolar patients from the U.S. compared to Europe. Journal of Affective Disorders. 191: 180-186. PMID 26655863 DOI: 10.1016/J.Jad.2015.11.038  0.214
2006 Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Development and Psychopathology. 18: 1181-211. PMID 17064434 DOI: 10.1017/S0954579406060573  0.213
1998 Parekh PI, Ketter TA, Altshuler L, Frye MA, Callahan A, Marangell L, Post RM. Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients. Biological Psychiatry. 43: 392-4. PMID 9513756 DOI: 10.1016/S0006-3223(97)00513-1  0.213
2015 Post RM. Heading off depressive illness evolution and progression to treatment resistance. Dialogues in Clinical Neuroscience. 17: 105-9. PMID 26246786  0.213
2002 Obrocea GV, Dunn RM, Frye MA, Ketter TA, Luckenbaugh DA, Leverich GS, Speer AM, Osuch EA, Jajodia K, Post RM. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biological Psychiatry. 51: 253-60. PMID 11839368 DOI: 10.1016/S0006-3223(01)01206-9  0.213
1986 Post RM, Rubinow DR, Uhde TW, Ballenger JC, Linnoila M. Dopaminergic Effects of Carbamazepine: Relationship to Clinical Response in Affective Illness Archives of General Psychiatry. 43: 392-396. PMID 3954558 DOI: 10.1001/Archpsyc.1986.01800040102014  0.212
2004 Post RM. Differing psychotropic profiles of the anticonvulsants in bipolar and other psychiatric disorders Clinical Neuroscience Research. 4: 9-30. DOI: 10.1016/j.cnr.2004.06.003  0.212
1986 Roy-Byrne PP, Uhde TW, Sack DA, Linnoila M, Post RM. Plasma HVA and anxiety in patients with panic disorder. Biological Psychiatry. 21: 849-53. PMID 3730466 DOI: 10.1016/0006-3223(86)90253-2  0.212
2008 Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant'Anna M, Cunha AB, Post RM. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 30: 243-5. PMID 18833425 DOI: 10.1590/S1516-44462008000300011  0.211
1990 Leverich GS, Post RM, Rosoff AS. Factors associated with relapse during maintenance treatment of affective disorders. International Clinical Psychopharmacology. 5: 135-56. PMID 2380544 DOI: 10.1097/00004850-199004000-00007  0.21
1990 Post RM. Prophylaxis of Bipolar Affective Disorders International Review of Psychiatry. 2: 277-320. DOI: 10.3109/09540269009026602  0.21
2008 Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews. 32: 675-92. PMID 18199480 DOI: 10.1016/J.Neubiorev.2007.10.005  0.21
2016 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Nolen WA. Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients severity of illness. Journal of Affective Disorders. 207: 313-319. PMID 27741468 DOI: 10.1016/J.Jad.2016.09.042  0.209
2004 Post RM, Chang KD, Suppes T. Treatment of rapid-cycling bipolar disorder. Cns Spectrums. 9: 1-11. PMID 15032235  0.209
1982 CUTLER NR, POST RM. State-Related Cyclical Dyskinesias in Manic-Depressive Illness Journal of Clinical Psychopharmacology. 2: 350???354. DOI: 10.1097/00004714-198210000-00013  0.209
2004 Post RM. The status of the sensitization/kindling hypothesis of bipolar disorder Current Psychosis & Therapeutics Reports. 2: 135-141. DOI: 10.1007/BF02629414  0.209
2017 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neuroscience and Biobehavioral Reviews. PMID 28119069 DOI: 10.1016/J.Neubiorev.2017.01.022  0.209
1986 Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitisation in the longitudinal course of affective illness British Journal of Psychiatry. 149: 191-201. PMID 3535979  0.208
1987 Post RM, Uhde TW, Rubinow DR, Huggins T. Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications. Psychiatry Research. 22: 11-9. PMID 3659217 DOI: 10.1016/0165-1781(87)90045-X  0.208
2011 Post RM, Weiss SR. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. Cns Neuroscience & Therapeutics. 17: 649-60. PMID 21159150 DOI: 10.1111/j.1755-5949.2010.00215.x  0.208
1985 Joffe RT, Post RM, Uhde TW. Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine. Archives of General Psychiatry. 42: 738. PMID 4015316 DOI: 10.1001/Archpsyc.1985.01790300106015  0.208
2007 Frye MA, Tsai GE, Huggins T, Coyle JT, Post RM. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biological Psychiatry. 61: 162-6. PMID 16735030 DOI: 10.1016/j.biopsych.2006.01.024  0.208
2013 Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. The British Journal of Psychiatry : the Journal of Mental Science. 202: 172-6. PMID 23457180 DOI: 10.1192/bjp.bp.112.116855  0.207
2000 Vawter MP, Frye MA, Hemperly JJ, VanderPutten DM, Usen N, Doherty P, Saffell JL, Issa F, Post RM, Wyatt RJ, Freed WJ. Elevated concentration of N-CAM VASE isoforms in schizophrenia. Journal of Psychiatric Research. 34: 25-34. PMID 10696830 DOI: 10.1016/S0022-3956(99)00026-6  0.207
1984 Kellner CH, Davenport Y, Post RM, Ross RJ. Rapidly cycling bipolar disorder and multiple sclerosis American Journal of Psychiatry. 141: 112-113. PMID 6691425 DOI: 10.1176/AJP.141.1.112  0.206
2022 Post RM, Leverich GS, McElroy SL, Kupka R, Suppes T, Altshuler LL, Nolen WA, Frye MA, Keck PE, Grunze H, Rowe M. Are personality disorders in bipolar patients more frequent in the US than Europe? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 58: 47-54. PMID 35227977 DOI: 10.1016/j.euroneuro.2022.02.007  0.206
2020 Post RM, Rowe M, Findling R. Little Agreement on Treating Residual Bipolar Disorder Symptoms in a Child. The Primary Care Companion For Cns Disorders. 22. PMID 32942345 DOI: 10.4088/PCC.19m02574  0.206
1980 Post RM, Ballenger JC, Hare TA, Goodwin FK, Lake CR, Jimerson DC, Bunney WE. Cerebrospinal fluid GABA in normals and patients with affective disorders Brain Research Bulletin. 5: 755-759. DOI: 10.1016/0361-9230(80)90124-0  0.206
1983 Kellner CH, Rubinow DR, Gold PW, Post RM. Relationship of cortisol hypersecretion to brain CT scan alterations in depressed patients Psychiatry Research. 8: 191-197. PMID 6574538 DOI: 10.1016/0165-1781(83)90062-8  0.206
2014 Soeiro-de-Souza MG, Post R, Machado-Vieira R, do Prado CM, Moreno RA, Akiskal H, Akiskal KK. Association study between COMT 158Met and creativity scores in bipolar disorder and healthy controls | Estudo de associação entre COMT 158Met e criatividade em sujeitos com transtorno bipolar e controles saudáveis Revista De Psiquiatria Clinica. 41: 29-33. DOI: 10.1590/0101-60830000000006  0.205
2001 Post RM, Weiss SR, Leverich GS, Smith M, Zhang L. Sensitization and kindling-like phenomena in bipolar disorder: implications for psychopharmacology Clinical Neuroscience Research. 1: 69-81. DOI: 10.1016/S1566-2772(00)00009-8  0.204
1996 Post R. Mechanisms of recurrence and cyclicity in the affective disorders: Implications for treatment European Neuropsychopharmacology. 6: 203. DOI: 10.1016/0924-977X(96)88254-X  0.204
1983 Rieder RO, Mann LS, Weinberger DR, van Kammen DP, Post RM. Computed tomographic scans in patients with schizophrenia, schizoaffective, and bipolar affective disorder. Archives of General Psychiatry. 40: 735-9. PMID 6860075 DOI: 10.1001/ARCHPSYC.1983.01790060033004  0.204
1990 Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Archives of Neurology. 47: 284-8. PMID 2106868 DOI: 10.1001/Archneur.1990.00530030050016  0.204
2020 Post RM. How to prevent the malignant progression of bipolar disorder. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32578689 DOI: 10.1590/1516-4446-2020-0874  0.203
1987 Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Research. 21: 71-83. PMID 2885878 DOI: 10.1016/0165-1781(87)90064-3  0.203
2016 Post RM, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Leverich GS, Nolen WA. Further Evidence of a Cohort Effect in Bipolar Disorder: More Early Onsets and Family History of Psychiatric Illness in More Recent Epochs. The Journal of Clinical Psychiatry. PMID 27379705 DOI: 10.4088/Jcp.15M10121  0.203
1987 Joffe RT, Uhde TW, Post RM, Minichiello MD. Motor activity in depressed patients treated with carbamazepine. Biological Psychiatry. 22: 941-6. PMID 3607135 DOI: 10.1016/0006-3223(87)90003-5  0.203
1988 Roy-Byrne PP, Post RM, Kellner CH, Joffe RT, Uhde TW. Ventricular-brain ratio and life course of illness in patients with affective disorder. Psychiatry Research. 23: 277-84. PMID 3387502 DOI: 10.1016/0165-1781(88)90018-2  0.203
1989 Hauser P, Dauphinais ID, Berrettini W, DeLisi LE, Gelernter J, Post RM. Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia. Biological Psychiatry. 26: 659-68. PMID 2804188 DOI: 10.1016/0006-3223(89)90100-5  0.202
2014 Post RM, Altshuler LL, Leverich GS, Nolen WA, Kupka R, Grunze H, Frye MA, Suppes T, McElroy SL, Keck PE, Rowe M. Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States. The Primary Care Companion For Cns Disorders. 16. PMID 25834764 DOI: 10.4088/Pcc.14M01677  0.202
1988 Roy-Byrne PP, Post RM, Hambrick DD, Leverich GS, Rosoff AS. Suicide and course of illness in major affective disorder. Journal of Affective Disorders. 15: 1-8. PMID 2970487 DOI: 10.1016/0165-0327(88)90002-X  0.202
1984 Joffe RT, Gold PW, Uhde TW, Post RM. The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone. Psychiatry Research. 12: 161-6. PMID 6433372 DOI: 10.1016/0165-1781(84)90016-7  0.201
2016 Post RM, Leverich GS, Speer AM, Xing G, Weiss SR. Neural mechanisms of childhood-onset bipolar illness. Acta Neuropsychiatrica. 12: 139-43. PMID 26975274 DOI: 10.1017/S0924270800035626  0.201
2010 Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotoxicity Research. 18: 256-71. PMID 20390474 DOI: 10.1007/s12640-010-9182-2  0.2
2000 Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. The American Journal of Psychiatry. 157: 1873-5. PMID 11058490  0.2
2006 Post RM, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE, Leverich GS, Kupka R, Nolen WA, Grunze H. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Current Psychiatry Reports. 8: 489-97. PMID 17162830 DOI: 10.1007/S11920-006-0056-5  0.2
2018 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder. Bipolar Disorders. PMID 29926532 DOI: 10.1111/Bdi.12668  0.2
1992 Post RM, Leverich GS, Altshuler L, Mikalauskas K. Lithium-discontinuation-induced refractoriness: preliminary observations. The American Journal of Psychiatry. 149: 1727-9. PMID 1443252 DOI: 10.1176/AJP.149.12.1727  0.199
1988 Post RM, Roy-Byrne PP, Uhde TW. Graphic representation of the life course of illness in patients with affective disorder. The American Journal of Psychiatry. 145: 844-8. PMID 3381929 DOI: 10.1176/Ajp.145.7.844  0.199
2011 Soeiro-de-Souza MG, Dias VV, Bio DS, Post RM, Moreno RA. Creativity and executive function across manic, mixed and depressive episodes in bipolar I disorder. Journal of Affective Disorders. 135: 292-7. PMID 21767880 DOI: 10.1016/j.jad.2011.06.024  0.199
2019 Goldstein BI, Post RM, Birmaher B. Debate: Fomenting controversy regarding pediatric bipolar disorder. Child and Adolescent Mental Health. 24: 95-96. PMID 31866767 DOI: 10.1111/camh.12318  0.198
2017 Post RM, Rowe M, Kaplan D, Findling RL. A Multisymptomatic Child With Bipolar Disorder: How to Track and Sequence Treatment. The Primary Care Companion For Cns Disorders. 19. PMID 28906604 DOI: 10.4088/PCC.17r02122  0.198
2000 Denicoff KD, Sollinger AB, Frye MA, Ali SO, Smith-Jackson EE, Leverich GS, Post RM. Neuroleptic exposure in bipolar outpatients in a research setting. Comprehensive Psychiatry. 41: 248-52. PMID 10929791 DOI: 10.1053/comp.2000.7430  0.198
1972 Post RM, Kotin J, Matzen M, Jones CC, Goodwin FK. Effect of serum from depressed and manic patients on maze behavior of rats Experientia. 28: 1471-1472. PMID 4654218 DOI: 10.1007/BF01957859  0.198
1981 Post RM, Pickar D, Naber D, Ballenger JC, Uhde TW, Bunney WE. Effect of carbamazepine on CSF opioid activity: Relationship to antidepressant response Psychiatry Research. 5: 59-66. DOI: 10.1016/0165-1781(81)90061-5  0.198
2013 Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Kupka RW, Grunze H, Rowe M. Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. Journal of Affective Disorders. 147: 288-94. PMID 23337654 DOI: 10.1016/J.Jad.2012.11.020  0.198
1984 Post RM, Uhde TW. Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications. Epilepsia. S97-108. PMID 6421569 DOI: 10.1111/J.1528-1157.1983.Tb04652.X  0.198
2019 Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA. Beyond Evidence-based Treatment of Bipolar Disorder: Rational Pragmatic Approaches to Management. Bipolar Disorders. PMID 31343802 DOI: 10.1111/Bdi.12813  0.198
2003 Post R, Speer A, Hough C, Xing G. Neurobiology of Bipolar Illness: Implications for Future Study and Therapeutics Annals of Clinical Psychiatry. 15: 85-94. DOI: 10.3109/10401230309085674  0.198
2004 Post RM, Weiss SR. Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders. Clinical Eeg and Neuroscience. 35: 14-24. PMID 15112460  0.197
2002 Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE, Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biological Psychiatry. 51: 305-11. PMID 11958781 DOI: 10.1016/S0006-3223(01)01217-3  0.197
2009 Post RM. Childhood-Onset Bipolar Disorder: The Perfect Storm Psychiatric Annals. 39: 879-886. DOI: 10.3928/00485718-20090924-06  0.197
1985 Uhde TW, Boulenger JP, Post RM, Siever LJ, Vittone BJ, Jimerson DC, Roy-Byrne PP. Fear and anxiety: relationship to noradrenergic function. Psychopathology. 8-23. PMID 6505121 DOI: 10.1159/000284127  0.196
1986 Kellner CH, Rubinow DR, Post RM. Cerebral ventricular size and cognitive impairment in depression Journal of Affective Disorders. 10: 215-219. PMID 2943775 DOI: 10.1016/0165-0327(86)90007-8  0.196
1998 Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 206-19. PMID 9653709 DOI: 10.1016/S0893-133X(98)00020-7  0.196
2015 Post RM, Altshuler L, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Kupka RW, Grunze H, Rowe M. Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. Comprehensive Psychiatry. 56: 21-8. PMID 25284280 DOI: 10.1016/J.Comppsych.2014.08.050  0.196
2015 Post RM, Altshuler L, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. Multigenerational Positive Family History of Psychiatric Disorders Is Associated With a Poor Prognosis in Bipolar Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych140802. PMID 26258489 DOI: 10.1176/Appi.Neuropsych.14080204  0.196
2003 Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, Post RM, Wassermann EM. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of prefrontal cortex rTMS. Biological Psychiatry. 54: 826-32. PMID 14550682 DOI: 10.1016/S0006-3223(03)00324-X  0.196
2007 Post RM. The case for polypharmacy in the treatment of bipolar disorder Psychiatric Times. 24: 32-37.  0.195
2007 Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuroscience and Biobehavioral Reviews. 31: 858-73. PMID 17555817 DOI: 10.1016/j.neubiorev.2007.04.003  0.195
2009 Post RM. Myth of evidence-based medicine for bipolar disorder. Expert Review of Neurotherapeutics. 9: 1271-3. PMID 19769442 DOI: 10.1586/ern.09.87  0.194
1999 Post RM. Comparative pharmacology of bipolar disorder and schizophrenia. Schizophrenia Research. 39: 153-8; discussion 16. PMID 10507527 DOI: 10.1016/S0920-9964(99)00115-2  0.194
1985 Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatrica Scandinavica. Supplementum. 317: 1-34. PMID 3861072 DOI: 10.1111/j.1600-0447.1985.tb10510.x  0.194
2000 Post RM, Leverich GS, Weiss SRB, Speer AM, Obrocea G, Denicoff KD. Cellular mechanisms in the cyclic affective disorders Acta Neurologica Scandinavica. 102: 5-52. DOI: 10.1034/j.1600-0404.2000.00202-9.x  0.194
2020 Singh MK, Chang KD, Goldstein B, Miklowitz DJ, Soutullo C, Youngstrom E, Birmaher B, Axelson D, Post RM, DelBello MP. Isn't the evidence base for pediatric bipolar disorder already sufficient to inform clinical practice? Bipolar Disorders. PMID 32844555 DOI: 10.1111/bdi.12987  0.193
1997 Post RM, Kramlinger KG, Joffe RT, Roy-Byrne PP, Rosoff A, Frye MA, Huggins T. Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Research. 72: 1-7. PMID 9355813 DOI: 10.1016/S0165-1781(97)00076-0  0.192
2008 Post RM. Promising avenues of therapeutics for bipolar illness. Dialogues in Clinical Neuroscience. 10: 193-201. PMID 18689289  0.192
2013 Post RM. Neglected treatment research in bipolar disorder: a congressional mandate would help. Expert Review of Neurotherapeutics. 13: 739-41. PMID 23898844 DOI: 10.1586/14737175.2013.811200  0.192
1998 Post RM, Weiss SRB, Li H, Smith MA, Zhang LX, Xing G, Osuch EA, Mccann UD. Neural plasticity and emotional memory Development and Psychopathology. 10: 829-855. PMID 9886229 DOI: 10.1017/S0954579498001898  0.192
1998 Post RM, Weiss SRB. Sensitization and kindling phenomena in mood, anxiety, and obsessive- compulsive disorders: The role of serotonergic mechanisms in illness progression Biological Psychiatry. 44: 193-206. PMID 9693391 DOI: 10.1016/S0006-3223(98)00144-9  0.192
1997 Post RM, Denicoff KD, Frye MA, Leverich GS. Re-evaluating carbamazepine prophylaxis in bipolar disorder British Journal of Psychiatry. 170: 202-204. DOI: 10.1192/S0007125000146525  0.192
2005 Born C, Dittmann S, Post RM, Grunze H. Newer prophylactic agents for bipolar disorder and their influence on suicidality. Archives of Suicide Research : Official Journal of the International Academy For Suicide Research. 9: 301-6. PMID 16020172 DOI: 10.1080/13811110590929541  0.191
2013 van Dijk A, Klanker M, van Oorschot N, Post R, Hamelink R, Feenstra MG, Denys D. Deep brain stimulation affects conditioned and unconditioned anxiety in different brain areas. Translational Psychiatry. 3: e289. PMID 23900312 DOI: 10.1038/Tp.2013.56  0.191
2014 Post RM. Why the discrepancy between antidepressant drug use and evidence base in bipolar disorder? Future Neurology. 9: 285-288. DOI: 10.2217/fnl.14.19  0.19
1997 Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. The Journal of Clinical Psychiatry. 58: 470-8. PMID 9413412  0.19
1997 McCann UD, Morgan CM, Geraci M, Slate SO, Murphy DL, Post RM. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 360-9. PMID 9397424 DOI: 10.1016/S0893-133X(97)00085-7  0.19
1997 Denicoff KD, Smith-Jackson EE, Disney ER, Suddath RL, Leverich GS, Post RM. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). Journal of Psychiatric Research. 31: 593-603. PMID 9368200 DOI: 10.1016/S0022-3956(96)00027-1  0.189
2019 Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MHJ, Pfennig A, Post RM, Preisig M, Ratheesh A, Salvatore P, et al. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disorders. PMID 31479581 DOI: 10.1111/Bdi.12831  0.189
1986 Joffe RT, Post RM, Ballenger JC, Rebar R, Rakita R, Gold PW. Neuroendocrine effects of the dopamine agonist piribedil in depressed patients. Clinical Neuropharmacology. 9: 448-55. PMID 3768867 DOI: 10.1097/00002826-198610000-00005  0.189
1973 Kotin J, Post RM, Goodwin FK. Drug treatment of depressed patients referred for hospitalization. The American Journal of Psychiatry. 130: 1139-41. PMID 4728909 DOI: 10.1176/AJP.130.10.1139  0.189
1986 Uhde TW, Vittone BJ, Siever LJ, Kaye WH, Post RM. Blunted growth hormone response to clonidine in panic disorder patients Biological Psychiatry. 21: 1081-1085. PMID 3741921 DOI: 10.1016/0006-3223(86)90291-X  0.188
2011 Post RM. Interview: Bipolar disorder treatment research: New initiatives needed Neuropsychiatry. 1: 21-26. DOI: 10.2217/npy.11.1  0.188
1992 Post RM. The psychobiology of dysphoric mania. Clinical Neuropharmacology. 624A-625A. PMID 1498976 DOI: 10.1097/00002826-199201001-00323  0.188
1991 Herman R, Obarzanek E, Mikalauskas KM, Post RM, Jimerson DC. The effects of carbamazepine on resting metabolic rate and thyroid function in depressed patients. Biological Psychiatry. 29: 779-88. PMID 2054452 DOI: 10.1016/0006-3223(91)90197-T  0.188
1994 Jones BP, Duncan CC, Mirsky AF, Post RM, Theodore WH. Neuropsychological profiles in bipolar affective disorder and complex partial seizure disorder. Neuropsychology. 8: 55-64. DOI: 10.1037/0894-4105.8.1.55  0.188
2019 Fredskild MU, Mintz J, Frye MA, McElroy SL, Nolen WA, Kupka R, Grunze H, Keck PE, Post RM, Kessing LV, Suppes T. Adding Increased Energy or Activity to Criterion (A) of the DSM-5 Definition of Hypomania and Mania: Effect on the Diagnoses of 907 Patients From the Bipolar Collaborative Network. The Journal of Clinical Psychiatry. 80. PMID 31665571 DOI: 10.4088/Jcp.19M12834  0.187
2007 Post RM. A 35-year-old female patient with bipolar disorder Psychiatric Annals. 37: 568-569.  0.187
1980 Jimerson DC, Post RM, van Kammen DP, Skyler JS, Brown GL, Bunney WE. Cerebrospinal fluid cortisol levels in depression and schizophrenia. The American Journal of Psychiatry. 137: 979-80. PMID 7416307 DOI: 10.1176/AJP.137.8.979  0.187
2014 Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Kupka RW, Grunze H, Rowe M. More medical comorbidities in patients with bipolar disorder from the United States than from the Netherlands and Germany. The Journal of Nervous and Mental Disease. 202: 265-70. PMID 24647213 DOI: 10.1097/Nmd.0000000000000116  0.186
1997 Denicoff KD, Smith-Jackson EE, Bryan AL, Ali SO, Post RM. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. The American Journal of Psychiatry. 154: 1456-8. PMID 9326833 DOI: 10.1176/AJP.154.10.1456  0.185
2001 Post RM, Leverich GS, Xing G, Weiss RB. Developmental vulnerabilities to the onset and course of bipolar disorder. Development and Psychopathology. 13: 581-98. PMID 11523849 DOI: 10.1017/S0954579401003091  0.185
2020 Post RM, Goldstein BI, Birmaher B, Findling RL, Frey BN, DelBello MP, Miklowitz DJ. Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data. Journal of Affective Disorders. 272: 508-520. PMID 32553395 DOI: 10.1016/J.Jad.2020.03.025  0.185
2020 Post RM. Early Detection and Preventive Treatment in Bipolar Disorder. The American Journal of Psychiatry. 177: 867. PMID 32880471 DOI: 10.1176/appi.ajp.2020.19111148  0.185
1999 Frye MA, Dunn RT, Gary KA, Kimbrell TA, Callahan AM, Luckenbaugh DA, Corá-Locatelli G, Vanderham E, Winokur A, Post RM. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biological Psychiatry. 45: 1049-52. PMID 10386189 DOI: 10.1016/S0006-3223(98)00322-9  0.184
1984 Siever LJ, Uhde TW, Jimerson DC, Lake CR, Silberman ER, Post RM, Murphy DL. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. The American Journal of Psychiatry. 141: 733-41. PMID 6329004 DOI: 10.1176/AJP.141.6.733  0.184
1980 Post RM, Ballenger JC, Hare TA, Bunney WE. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid. Neurology. 30: 1008-11. PMID 7191529 DOI: 10.1212/Wnl.30.9.1008  0.183
2008 Osuch EA, Cora-Locatelli G, Frye MA, Huggins T, Kimbrell TA, Ketter TA, Callahan AM, Post RM. Post-dexamethasone cortisol correlates
with severity of depression before and
during carbamazepine treatment in women but not men Acta Psychiatrica Scandinavica. 104: 397-401. DOI: 10.1111/j.1600-0447.2001.00395.x  0.182
2021 Post RM. The Kindling/Sensitization Model and Early Life Stress. Current Topics in Behavioral Neurosciences. PMID 33432554 DOI: 10.1007/7854_2020_172  0.182
2014 Post RM, Leverich GS, Kupka R, Keck P, McElroy S, Altshuler L, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA. Increased parental history of bipolar disorder in the United States: association with early age of onset. Acta Psychiatrica Scandinavica. 129: 375-82. PMID 24138298 DOI: 10.1111/Acps.12208  0.182
2002 Keck PE, Freeman MP, McElroy SL, Altshuler LL, Denicoff KD, Nolen WA, Suppes T, Frye M, Kupka R, Leverich GS, Grunze H, Walden J, Post RM. A double-blind, placebo-controlled trial of eicosapentanoic acid in rapid cycling bipolar disorder Bipolar Disorders. 4: 26-27. DOI: 10.1034/J.1399-5618.4.S1.4.X  0.182
1977 Jimerson DC, Lynch HJ, Post RM, Wurtman RJ, Bunney WE. Urinary melatonin rhythms during sleep deprivation in depressed patients and normals. Life Sciences. 20: 1501-8. PMID 559896 DOI: 10.1016/0024-3205(77)90441-6  0.181
2012 Post RM. The sorry state of treatment research in bipolar disorder: an ongoing but preventable catastrophe. The Journal of Nervous and Mental Disease. 200: 924-7. PMID 23124174 DOI: 10.1097/NMD.0b013e31827189d4  0.181
2003 Curtin F, Post RM, Keck PE, Rush AJ. Bipolar disorder and crossover design [5] (multiple letters) Journal of Clinical Psychopharmacology. 23: 319-320. PMID 12826998 DOI: 10.1097/00004714-200306000-00017  0.181
2010 Post RE, Dickerson LM. Dizziness: a diagnostic approach. American Family Physician. 82: 361-8, 369. PMID 20704166  0.18
2003 Post RM, Keck, PE, Rush AJ. Bipolar Disorder and Crossover Design Journal of Clinical Psychopharmacology. 23: 320. DOI: 10.1097/00004714-200306000-00018  0.18
1998 Leverich GS, Post RM. Life Charting of Affective Disorders Cns Spectrums. 3: 21-37. DOI: 10.1017/S1092852900031138  0.18
1972 Ebert MH, Post RM, Goodwin FK. Effect of physical activity on urinary M.H.P.G. excretion in depressed patients. Lancet (London, England). 2: 766. PMID 4116183 DOI: 10.1016/S0140-6736(72)92064-8  0.179
2004 Post RM, Chang KD, Findling RL, Geller B, Kowatch RA, Kutcher SP, Leverich GS. Prepubertal bipolar I disorder and bipolar disorder NOS are separable from ADHD. The Journal of Clinical Psychiatry. 65: 898-902. PMID 15291676 DOI: 10.4088/Jcp.V65N0703  0.178
2014 Kapczinski F, Magalhães PV, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant'Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatrica Scandinavica. 130: 354-63. PMID 24961757 DOI: 10.1111/Acps.12305  0.177
2018 Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, ... ... Post RM, et al. Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. The Australian and New Zealand Journal of Psychiatry. 4867418808382. PMID 30378461 DOI: 10.1177/0004867418808382  0.177
2004 ALTSHULER L, SUPPES T, BLACK D, LUCKENBAUGH D, POST R. Dr. Altshuler and Colleagues Reply American Journal of Psychiatry. 161: 1313-1313. DOI: 10.1176/Appi.Ajp.161.7.1313  0.177
2016 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders. Journal of Psychiatric Research. 81: 63-70. PMID 27392070 DOI: 10.1016/J.Jpsychires.2016.06.008  0.177
2006 Post RM, Kowatch RA. The health care crisis of childhood-onset bipolar illness: some recommendations for its amelioration. The Journal of Clinical Psychiatry. 67: 115-25. PMID 16426098 DOI: 10.4088/Jcp.V67N0118  0.177
2021 Singh MK, Post RM, Miklowitz DJ, Birmaher B, Youngstrom E, Goldstein B, Soutullo C, Axelson D, Chang KD, DelBello MP. A Commentary on Youth Onset Bipolar Disorder. Bipolar Disorders. PMID 34689401 DOI: 10.1111/bdi.13148  0.176
2020 Post RM. A shocking deficit in bipolar disorder treatment research funding. Bipolar Disorders. PMID 32989875 DOI: 10.1111/bdi.13010  0.176
2018 Post RM. Myriad of implications of acetyl-l-carnitine deficits in depression. Proceedings of the National Academy of Sciences of the United States of America. PMID 30068605 DOI: 10.1073/pnas.1811389115  0.176
1979 Rey AC, Savard RJ, Silber E, Buchsbaum MS, Post RM. Cognitive changes and the averaged evoked response in depression Cognitive Therapy and Research. 3: 263-267. DOI: 10.1007/BF01185966  0.176
2002 Post RM, Keck P, Rush AJ. New designs for studies of the prophylaxis of bipolar disorder. Journal of Clinical Psychopharmacology. 22: 1-3. PMID 11799335 DOI: 10.1097/00004714-200202000-00001  0.176
1994 Denicoff KD, Blake KD, Smith-Jackson EE, Jacob PA, Leverich G, Post RM. Morbidity in treated bipolar disorder: A one-year prospective study using daily life chart ratings Depression. 2: 95-104. DOI: 10.1002/DEPR.3050020206  0.175
2020 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Nolen WA. Double jeopardy in the United States: Early onset bipolar disorder and treatment delay. Psychiatry Research. 292: 113274. PMID 32731080 DOI: 10.1016/J.Psychres.2020.113274  0.175
2014 Post RM. This issue: Part 2: Differentiating pediatric bipolar disorder from attention-deficit/hyperactivity disorder Psychiatric Annals. 44: 455. DOI: 10.3928/00485713-20141003-03  0.175
2014 Post RM. This issue: Differentiating pediatric bipolar disorder from Attention-Deficit/Hyperactivity disorder Psychiatric Annals. 44. DOI: 10.3928/00485713-20140908-03  0.175
2014 Post RM, Findling RL, Luckenbaugh DA. Number, severity, and quality of symptoms discriminate early-onset bipolar disorder from Attention-Deficit/Hyperactivity disorder Psychiatric Annals. 44: 416-422. DOI: 10.3928/00485713-20140908-05  0.175
1984 Uhde TW, Vittone BJ, Post RM. Glucose tolerance testing in panic disorder. The American Journal of Psychiatry. 141: 1461-3. PMID 6496793 DOI: 10.1176/AJP.141.11.1461  0.174
1986 Roy-Byrne PP, Weingartner H, Bierer LM, Thompson K, Post RM. Effortful and automatic cognitive processes in depression. Archives of General Psychiatry. 43: 265-7. PMID 3954546 DOI: 10.1001/archpsyc.1986.01800030083008  0.174
1997 Ketter TA, Malow BA, Post RM, Theodore WH. Psychiatric effects of felbamate. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 118-9. PMID 9017538 DOI: 10.1176/jnp.9.1.118  0.174
2009 Post RM, Wozniak J. Survey of expert treatment approaches for children with bipolar disorder-not otherwise specified and bipolar-I presentations Psychiatric Annals. 39: 887-895. DOI: 10.3928/00485718-20090924-07  0.174
1974 POST RM, KOTIN J, GOODWIN FK. The Effects of Cocaine on Depressed Patients American Journal of Psychiatry. 131: 511-517. DOI: 10.1176/AJP.131.5.511  0.174
1984 Zuckerman M, Ballenger JC, Post RM. The Neurobiology of Some Dimensions of Personality International Review of Neurobiology. 25: 391-436. PMID 6469473 DOI: 10.1016/S0074-7742(08)60685-6  0.173
2015 Nassan M, Croarkin PE, Luby JL, Veldic M, Joshi PT, Mcelroy SL, Post RM, Walkup JT, Cercy K, Geske JR, Wagner KD, Cuellar-Barboza AB, Casuto L, Lavebratt C, Schalling M, et al. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder Bipolar Disorders. 17: 645-652. DOI: 10.1111/bdi.12323  0.173
1984 Post RM, Rubinow DR, Gold PW. NON-OPIATE PEPTIDES IN THE CEREBROSPINAL FLUID OF PATIENTS WITH NEUROPSYCHIATRIC DISORDERS Clinical Neuropharmacology. 7: S394. DOI: 10.1097/00002826-198406001-00360  0.171
1985 Rubinow DR, Hoban C, Roy-Byrne P, Grover GN, Post RM. Premenstrual syndromes: Past and future research strategies Canadian Journal of Psychiatry. 30: 469-473. PMID 4075272  0.17
2014 Post RM, Altshuler L, Kupka R, McElroy S, Frye MA, Rowe M, Leverich GS, Grunze H, Suppes T, Keck PE, Nolen WA. More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. Journal of Affective Disorders. 160: 27-33. PMID 24709019 DOI: 10.1016/J.Jad.2014.02.006  0.17
2001 Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J. The Stanley Foundation Bipolar Network. I. Rationale and methods. The British Journal of Psychiatry. Supplement. 41: s169-76. PMID 11450179 DOI: 10.1192/bjp.178.41.s169  0.17
2013 Post RM, Chang K, Frye MA. Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention. The Journal of Clinical Psychiatry. 74: 167-9. PMID 23473349 DOI: 10.4088/JCP.12com08136  0.17
1994 Ketter TA, Malow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal-emergent psychopathology. Neurology. 44: 55-61. PMID 8290092 DOI: 10.1212/WNL.44.1.55  0.169
2018 Post RM. Disturbing Lack of Early Intervention Studies in Bipolar Disorder. Jama Psychiatry. 75: 1201-1202. PMID 30422264 DOI: 10.1001/jamapsychiatry.2018.2396  0.169
2023 Gomes FA, Soleas EK, Kcomt A, Duffy A, Milev R, Post RM, Bauer M, Brietzke E. Practices, knowledge, and attitudes about lithium treatment: Results of online surveys completed by clinicians and lithium-treated patients. Journal of Psychiatric Research. 164: 335-343. PMID 37393799 DOI: 10.1016/j.jpsychires.2023.06.005  0.169
2003 Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, Post RM, Wassermann EM. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: I. Effects of primary motor cortex rTMS. Biological Psychiatry. 54: 818-25. PMID 14550681 DOI: 10.1016/S0006-3223(03)00002-7  0.169
2007 McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disorders. 9: 426-34. PMID 17547588 DOI: 10.1111/J.1399-5618.2007.00488.X  0.168
1980 Silberman EK, Post RM. The march of symptoms in a psychotic decompensation. Case report and theoretical implications. The Journal of Nervous and Mental Disease. 168: 104-10. PMID 7354306 DOI: 10.1097/00005053-198002000-00007  0.168
2015 Nassan M, Croarkin PE, Luby JL, Veldic M, Joshi PT, McElroy SL, Post RM, Walkup JT, Cercy K, Geske JR, Wagner KD, Cuellar-Barboza AB, Casuto L, Lavebratt C, Schalling M, et al. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disorders. 17: 645-52. PMID 26528762 DOI: 10.1111/bdi.12323  0.168
2001 Osuch EA, Benson B, Geraci M, Podell D, Herscovitch P, McCann UD, Post RM. Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder. Biological Psychiatry. 50: 246-53. PMID 11522258 DOI: 10.1016/S0006-3223(01)01107-6  0.168
1987 Weiss SRB, Nguyen T, Rubinow DR, Helke CJ, Narang PK, Post RM, Jacobowitz DM. Lack of effect of chronic carbamazepine on brain somatostatin in the rat Journal of Neural Transmission. 68: 325-333. PMID 2881977 DOI: 10.1007/BF02098507  0.168
2018 van der Markt A, Klumpers UMH, Draisma S, Dols A, Nolen WA, Post RM, Altshuler LL, Frye MA, Grunze H, Keck PE, McElroy SL, Suppes T, Beekman ATF, Kupka RW. Testing a Clinical Staging Model for Bipolar Disorder using Longitudinal Life Chart Data. Bipolar Disorders. PMID 30447123 DOI: 10.1111/Bdi.12727  0.167
1983 Post RM, Uhde TW, Ballenger JC, Chatterji DC, Greene RF, Bunney WE. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Archives of General Psychiatry. 40: 673-6. PMID 6847334 DOI: 10.1001/Archpsyc.1983.04390010083010  0.167
1985 Rubinow DR, Post RM, Gold PW, Ballenger JC, Reichlin S. Effects of carbamazepine on cerebrospinal fluid somatostatin Psychopharmacology. 85: 210-213. PMID 2861620 DOI: 10.1007/BF00428416  0.167
1997 Post RM, Denicoff KD, Leverich GS, Frye MA. Drug-Induced Switching in Bipolar Disorder Cns Drugs. 8: 352-365. DOI: 10.2165/00023210-199708050-00002  0.166
1995 Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R, Post RM. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proceedings of the National Academy of Sciences of the United States of America. 92: 8788-92. PMID 7568018 DOI: 10.1073/PNAS.92.19.8788  0.166
1989 Kramlinger KG, Post RM. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatrica Scandinavica. 79: 378-85. PMID 2500006 DOI: 10.1111/j.1600-0447.1989.tb10273.x  0.165
1986 Klein E, Uhde TW, Post RM. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. The American Journal of Psychiatry. 143: 235-6. PMID 2868666 DOI: 10.1176/AJP.143.2.235  0.165
2016 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. Age at Onset of Bipolar Disorder Related to Parental and Grandparental Illness Burden. The Journal of Clinical Psychiatry. PMID 27631141 DOI: 10.4088/Jcp.15M09811  0.164
1998 Frye MA, Kimbrell TA, Dunn RT, Piscitelli S, Grothe D, Vanderham E, Corá-Locatelli G, Post RM, Ketter TA. Gabapentin does not alter single-dose lithium pharmacokinetics. Journal of Clinical Psychopharmacology. 18: 461-4. PMID 9864078 DOI: 10.1097/00004714-199812000-00008  0.162
2003 Fergus EL, Miller RB, Luckenbaugh DA, Leverich GS, Findling RL, Speer AM, Post RM. Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children. Journal of Affective Disorders. 77: 71-8. PMID 14550937 DOI: 10.1016/S0165-0327(02)00176-3  0.162
1985 Silberman EK, Putnam FW, Weingartner H, Braun BG, Post RM. Dissociative states in multiple personality disorder: a quantitative study. Psychiatry Research. 15: 253-60. PMID 3865243 DOI: 10.1016/0165-1781(85)90062-9  0.162
2019 Post RM. Bipolar II Disorder: Not So Sure It Is Time for Something New. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719852097. PMID 31104479 DOI: 10.1177/0706743719852097  0.161
1983 Sternberg DE, van Kammen DP, Lerner P, Ballenger JC, Marder SR, Post RM, Bunney WE. CSF dopamine beta-hydroxylase in schizophrenia. Archives of General Psychiatry. 40: 743-7. PMID 6134515 DOI: 10.1001/Archpsyc.1983.01790060041005  0.161
1985 Silberman EK, Post RM, Nurnberger J, Theodore W, Boulenger JP. Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy. The British Journal of Psychiatry : the Journal of Mental Science. 146: 81-9. PMID 3978348 DOI: 10.1192/BJP.146.1.81  0.161
2018 Post RM. Preventing the Malignant Transformation of Bipolar Disorder. Jama. PMID 29507950 DOI: 10.1001/jama.2018.0322  0.161
2021 Kupka R, Duffy A, Scott J, Almeida J, Balanzá-Martínez V, Birmaher B, Bond DJ, Brietzke E, Chendo I, Frey BN, Grande I, Hafeman D, Hajek T, Hillegers M, Kauer-Sant'Anna M, ... ... Post R, et al. Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disorders. PMID 34174130 DOI: 10.1111/bdi.13105  0.161
1997 Post RM, Weiss SRB, Smith M, Li H, McCann U. Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder Annals of the New York Academy of Sciences. 821: 285-295. PMID 9238212 DOI: 10.1111/J.1749-6632.1997.Tb48287.X  0.16
2003 Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. The American Journal of Psychiatry. 160: 883-9. PMID 12727691 DOI: 10.1176/Appi.Ajp.160.5.883  0.158
2002 Leverich GS, McElroy SL, Suppes T, Keck PE, Denicoff KD, Nolen WA, Altshuler LL, Rush AJ, Kupka R, Frye MA, Autio KA, Post RM. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biological Psychiatry. 51: 288-97. PMID 11958779  0.158
1987 Marangos PJ, Montgomery P, Weiss SRB, Patel J, Post RM. Persistent upregulation of brain adenosine receptors in response to chronic carbamazepine treatment Clinical Neuropharmacology. 10: 443-448. PMID 3503683 DOI: 10.1097/00002826-198710000-00006  0.158
2010 Post RM. Overlaps Between Schizophrenia and Bipolar Disorder Psychiatric Annals. 40: 106-112. DOI: 10.3928/00485718-20100127-07  0.157
1990 Putnam FW, Zahn TP, Post RM. Differential autonomic nervous system activity in multiple personality disorder. Psychiatry Research. 31: 251-60. PMID 2333357 DOI: 10.1016/0165-1781(90)90094-L  0.156
2021 Stevens AWMM, Draisma S, Goossens PJJ, Broekman BFP, Honig A, der Klein EAMK, Nolen WA, Post RM, Kupka RW. The course of bipolar disorder in pregnant versus non-pregnant women. International Journal of Bipolar Disorders. 9: 35. PMID 34734318 DOI: 10.1186/s40345-021-00239-z  0.156
1988 Post RM. Approaches to treatment-resistant bipolar affectively ill patients. Clinical Neuropharmacology. 11: 93-104. PMID 3132326 DOI: 10.1097/00002826-198804000-00001  0.155
2016 Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention. Bipolar Disorders. 18: 315-24. PMID 27346321 DOI: 10.1111/bdi.12401  0.155
1974 Post RM, Gillin JC, Wyatt RJ, Goodwin FK. The effect of orally administered cocaine on sleep of depressed patients. Psychopharmacologia. 37: 59-66. PMID 4370448 DOI: 10.1007/BF00426683  0.155
2010 Post RM, Kauer-Sant'Anna M. An Introduction to the Neurobiology of Bipolar Illness Onset, Recurrence and Progression Bipolar Disorder: Clinical and Neurobiological Foundations. 96-109. DOI: 10.1002/9780470661277.ch11  0.154
1988 Kahn JP, Rubinow DR, Davis CL, Kling M, Post RM. Salivary cortisol: A practical method for evaluation of adrenal function Biological Psychiatry. 23: 335-349. PMID 3257706 DOI: 10.1016/0006-3223(88)90284-3  0.154
1979 Reus VI, Targum SD, Weingartner H, Post RM. Effect of lithium carbonate on memory processes of bipolar affectively ill patients. Psychopharmacology. 63: 39-42. PMID 112620 DOI: 10.1007/BF00426919  0.153
Hide low-probability matches.